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Abstract 
The cap structure of polymerase II transcripts is pivotal to protect RNAs from degradation and features a 
platform to recruit factors involved in RNA processing and export. Among the most essential binding 
partners of mRNA is the cap-binding complex (CBC) consisting of the nuclear cap-binding protein 1 
(NCBP1) and the direct cap-binding subunit NCBP2. The CBC was long believed to be critically required 
for mRNA processing and export.  
In the main project of my Ph.D. thesis, I showed that the cap-binding subunit NCBP2 is dispensable for 
export of bulk mRNA. I investigated the cellular repertoire of cap-binding proteins to identify candidates 
that could compensate for the loss of NCBP2. Using mass spectrometry, I identified the uncharacterized 
C17orf85 as a cap-binding protein that binds the RNA cap structure depending on the N7-methyl group 
of the guanosine. Furthermore, C17orf85 directly binds NCBP1 to assemble an alternative cap-binding 
complex, which has redundant function with the canonical CBC under steady-state conditions. 
Considering the function of C17orf85, we renamed the protein to nuclear cap-binding protein 3 
(NCBP3). Using loss of function experiments, I demonstrated that the function of NCBP3 is required to 
mount proper antiviral responses and to prevent viral spread highlighting the fundamental role of the 
alternative CBC in the adaptation to environmental stimuli.  
In a minor project of my thesis, I investigated the influence of serine S225 phosphorylation of the 
non-structural 5A (NS5A) protein of hepatitis C virus for interactions with cellular proteins. My 
collaboration partners further investigated the phosphorylation-dependent NS5A interaction partners for 
their requirement in viral replication. 
Taken together, this thesis describes the molecular and functional characterization of the alternative 
cap-binding complex consisting of NCBP1 and NCBP3. Furthermore, it highlights the importance of 
post-translational modifications like phosphorylation for the interaction potential and the function of a 
protein. 
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Preface 
This thesis is written in a cumulative style. The first part of chapter one is a general introduction to the 
biological background of RNA biology, particular focusing on RNA export pathways. The second and 
third part of chapter one describes the discrimination of self and non-self RNA , the viral manipulation of 
mRNA export as well as the importance of viral RNA-binding proteins for the success of viral replication. 
Section 1.2.1 of the introduction was published in Journal of Cytokine and Interferon Research: 
Gebhardt, A. *, Laudenbach, B.T. *, and Pichlmair, A. (2017). Discrimination of Self and Non-Self 
Ribonucleic Acids. J. Interf. Cytokine Res. 37, 184–197. *these authors contributed equally 
The second chapter includes my results in form of three manuscripts already published or prepared for 
submission: 
Gebhardt, A.*, Habjan, M.*, Benda, C., Meiler, A., Haas, D.A., Hein, M.Y., Mann, A., Mann, M., 
Habermann, B., and Pichlmair, A. (2015). mRNA export through an additional cap-binding complex 
consisting of NCBP1 and NCBP3. Nat. Commun. 6, 8192. *these authors contributed equally 
Goonawardane, N., Gebhardt, A., Bartlett, C., Pichlmair, A., and Harris, M. (2017). Phosphorylation 
of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions. J. Virol. JVI.00805-17. 
Gebhardt, A., Schnepf, D., Moser, M., Meiler, A., Michaudel, C., Mackowiak, C., Sedda, D., 
Stukalov, A., Reinert, L., Paludan, S.R., Ryffel, B., Stäheli, P., and Pichlmair, A. (2018). The alternative 
cap-binding complex is required for antiviral response in vivo. (prepared for submission) 
The last chapter features concluding remarks and a brief outlook. 
All publications are reprinted with permission and copyright of the publications belongs to the publishers. 
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1 Introduction 
1.1 RNA processing and nuclear export 
1.1.1 Nucleocytoplasmic compartmentalization 
In eukaryotic cells, evolutional pressure has led to the development of a physical separation 
between transcription and translation. This physical barrier, namely the nuclear envelope (NE) 
consisting of a double membrane, separates the nucleus that is the site of DNA storage and RNA 
synthesis from the cytoplasm where protein synthesis is executed. The development of this 
compartmentalization also triggered the establishment of transport machineries to passage 
macromolecules between the nucleus and the cytoplasm. One part of this machinery is the nuclear 
pore complex (NPC) that is embedded in the NE and controls the export and import of 
macromolecules together with a family of conserved transport receptors known as karyopherins 
or importin-ß-like transport receptors. The NPC is built up of approximately 30 different proteins 
called nucleoporins (Nups) that build up a 60-125 MDa structure 1. This permits the passage of 
proteins, RNAs and other soluble compounds. While small molecules (less than 40 kDa) can pass 
the NPC by diffusion, larger complexes like messenger (m) RNA need energy to shuttle through 
the pore 2. Transport receptors selectively recognize their cargos by binding short peptide signals 
named nuclear localization signal (NLS) and nuclear export signal (NES). Additionally, specific 
receptors can detect nucleotide motifs in RNAs enabling their export to the cytoplasm. Through 
the recognition of these signals, proteins that function in the nucleus such as histones or 
transcription factors can be imported into the nucleus, whereas, ribonucleic acids (RNAs) that 
mostly carry out their function or a processed in the cytoplasm are transported to the cytoplasm. 
Researchers demonstrated that one million macromolecules per minute are transported between 
the two compartments of a living cell 3.  
Even though there are different transport pathways, they all follow the same principles. The 
common feature of transport is the binding of the small GTPase Ran, which can switch between 
a GTP- and GDP-bound state (Figure 1). Ran exists in a GTP-bound form in the nucleus and a 
GDP-bound form in the cytoplasm. This gradient is generated by the existence of the 
Ran-guanosine-nucleotide exchange factor (RanGEF), which localizes to the nucleus, and the 
Ran-GTPase activating protein (RanGAP), which functions in the cytoplasm. The asymmetric 
distribution of RanGTP and -GDP drives the nucleocytoplasmic transport direction of the 
transport receptors (Figure 1).  
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Figure 1: Nuclear import and export of macromolecules. 
The left site represents the import cycle of importin ß-like transport receptor. Cargos are bound by importins, which mediate 
translocation of the cargo through the nuclear pore. In the nucleus, importins associate with RanGTP resulting in the release of 
the cargo. RanGTP-bound importins are recycled back to the cytoplasm where GTP hydrolysis drives the release of importins. In 
turn, importins can bind new cargos and the cycle restarts. The export cycle (right) is characterized by the binding of exportin to 
its cargo in the nucleus in a RanGTP-dependent manner. The bound RanGTP-exportin-cargo complex is shuttled to the cytoplasm 
interacting with nuclear pore subunits. On the cytoplasmic site, GTP hydrolyses results in release of the cargo and free exportin 
is recycled back to nucleus. Schematic and figure legend were adapted from reference 4. 
Importins, which are karyopherins that bind cargos in the cytoplasm and import them into the 
nucleus, bind RanGTP in the nucleus, which drives the release of the cargos. In its RanGTP bound 
state, importin is transported back to the cytoplasm, where GTP hydrolysis results in RanGDP 
and disposal of importin, which in return can interact with a new cargo. In contrast, karyopherins 
that passage cargos from the nucleus to the cytoplasm are called exportins. These exportins bind 
their cargo in a RanGTP bound form in the nucleus and transport them to the cytoplasm, where 
GTP hydrolysis drives the release of the cargo and unbound exportin can be located back to the 
nucleus to bind new cargo. All molecules, including proteins and most RNAs (transfer (t), micro 
(mi), small nuclear (sn) and ribosomal (r) RNA) that are larger than 40 kDa and need to bypass 
the barrier of the nuclear envelope, follow these general principles. However, one exception is 
the export of mRNA. The export of this macromolecule is mechanistically different from the 
others since it uses a karyopherin-unrelated transport receptor and is not dependent on the 
RanGTP/GDP gradient. The export of mRNA requires the fine-tuned combination of additional 
transport adaptor and release factors, which makes this export process more sophisticated and 
controlled. The following section will provide an overview of the major RNA export pathways 
and their differences. 
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1.1.2 Insights from small RNAs: tRNA, miRNA, rRNA and snRNA 
Commonly, all RNA classes are processed in the nucleus to a mature and thereby 
export-competent molecule. The classes of small RNAs, including tRNAs, miRNAs, rRNA and 
snRNAs, follow the general principles of nuclear to cytoplasmic transport dependent on 
karyopherins and the selective and directional Ran cycle 5. In this section, the differences in export 
routes of selective RNAs are introduced. 
1.1.2.1 Processing and export of tRNAs 
Transfer RNAs are loaded with amino acids (AAs) and are required in the cytoplasm during 
translation to provide the ribosomal complex with AAs for peptide chain elongation. About 40 
different tRNAs (in eukaryotic cells) need to be transported from their place of synthesis in the 
nucleus to the cytoplasm, where they function in translation. After synthesis by polymerase III, 
tRNAs are processed by multiple maturation events including trimming of the 3` and 5`trailer 
sequence, modification of nucleotides, addition of the 3`CCA nucleotide which serves as the AA 
acceptor stem and removal of introns (when present) (Figure 2a) 6,7. It is believed that maturation 
steps occur in the nucleus and are essential for proper export 8,9, which was also shown through 
the finding that exportin-t (XPOT) only weakly interacts with tRNAs lacking the trimmed 5` or 
3`end or required modifications 10–12. Surprisingly, studies injecting XPOT and intron-containing 
tRNA in Xenopus oocytes showed that XPOT can bind and export tRNAs containing introns 10,12. 
However, since intron removal was shown to occur before 5`end processing, in physiological 
conditions export of in-mature tRNAs should not be likely 13. Interestingly, cumulative studies 
carried out in yeast suggest that tRNA can be re-imported to the nucleus in an event called 
retrograde process 14–21. It was implicated that the re-import of tRNAs could be an intra-nuclear 
quality control mechanism or important for tRNA modifications 22,23 and is accelerated during 
starved cellular conditions 14,18,19,23,24. Conflicting studies not only in different yeast strains but also 
in vertebrates are currently challenging if tRNAs are retrograded to the nucleus in response to 
nutrient stress, which was to date only clearly shown in Saccharomyces cerevisiae 24–28. Following 
maturation in the nucleus, tRNAs ensue the general export principles using a karyopherin-ß family 
transport receptor and RanGTP (Figure 2a). The classical tRNA export route includes XPOT as 
transport receptor that preferentially binds tRNA in the nucleus and is favored by the association 
of RanGTP 11,29. It is believed that XPOT interacts with Nups and translocates the trimeric 
XPOT-tRNA-RanGTP complex through the nuclear pore. Subsequently in the cytoplasm, 
RanGAP stimulates the hydrolysis of GTP and consequently GDP is produced and the tRNA is 
released from its receptor, which in turn is recycled back to the nucleus. In addition to XPOT, it 
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has also been shown that exportin-5 (XPO5), which has its main function in miRNA export (see 
chapter 1.1.2.2), can also associate with tRNAs and export them in a similar manner to XPOT 
30,31. Furthermore, studies on the yeast XPOT orthologue LOS1 showed that LOS1 is not essential 
for viability and that certain tRNA species are not impaired in export by the depletion of LOS1 
32. This suggests that some tRNAs are translocated to the cytoplasm independent of LOS1 
indicating that alternative tRNA export receptors or even novel pathways are still unexplored. 
 
Figure 2: Schematic view of tRNA processing and export. 
Genes coding for tRNAs are transcribed by RNA polymerase III. The primary transcript is processed including 5`- and 3`end 
trimming, base modifications (red circles), 3`end CCA-nucleotide (amino acid acceptor site) addition and intron removal (if 
present). tRNAs ensue the general export principles using a karyopherin-ß family transport receptor and RanGTP. In this manner, 
export mature tRNAs bind XPOT and RanGTP and the trimeric XPOT-tRNA-RanGTP complex is translocated to the cytoplasm 
by interactions with the nuclear pore complex. Other less well characterized pathways may include XPO5, the main export 
receptor for miRNAs. Upon GTP hydrolysis in the cytoplasm, XPOT is translocated back to the nucleus and the released tRNA 
is located to the translational machinery. Schematic and figure legend were adapted from reference 5. 
1.1.2.2 Processing and export of miRNAs 
Micro RNAs play a central role in the regulation of a wide range of biological processes such as 
cell proliferation, developmental timing, organogenesis, apoptosis and immunity against viruses 
33–35. In that manner, targeted mRNAs are degraded by the activity of the RNA-induced silencing 
complex (RISC), which is guided to its target by the hybridization of the integrated miRNA 36.  
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Micro RNAs are encoded by genes that are mainly transcribed by polymerase II and thereby carry 
a 5`cap structure and a polyadenylated (poly(A)) tail similar to mRNA (see chapter 1.1.3 for more 
details) 37,38. In 2006, Borchert et al. showed that polymerase III can also transcribe miRNAs in 
some cases 39. Polymerase II transcribed miRNA sequences are found within introns or located at 
separate genomic loci and are produced as primary miRNAs (pri-miRNA) transcripts. Before 
function in the RISC complex, pri-miRNAs are processed in both the nucleus and the cytoplasm 
(Figure 3). Canonically, the pri-miRNAs are first cleaved by the nuclear type III RNase called 
DROSHA and its adaptor protein DGCR8 producing a 60-80 nucleotide (nt) long stem-looped 
precursor miRNA (pre-miRNA) with two nt overhangs at the 3`end 40–43. The unique structure 
of pre-miRNAs are recognized and bound by the karyopherin ß-family export receptor XPO5 and 
subsequently exported in a RanGTP-dependent manner 44–47. Upon GTP hydrolysis and release 
of the pre-miRNA in the cytoplasm, the stem-loop gets further cleaved by the cytoplasmic type 
III RNase DICER which results in a ~22 nt RNA duplex product 48. Finally, one strand of the fully 
processed miRNA is incorporated via the argonaute (AGO) protein into the RISC complex where 
it functions in the recognition of the target sequence by base pairing with the 3`untranslated region 
(3`UTR) (Figure 3) 48–50.  
Additional to the canonical pathway, several alternative mechanisms have been described to be 
involved in the generation of miRNA or miRNA-like RNAs (Figure 3) 51. The 
DROSHA/DGCR8-independent pathway was first identified during mRNA splicing in which a 
small RNA precursor (Mirtron) is generated bypassing the DROSHA/DGCR8-mediated 
processing step 52,53. Similar to the canonical pathway, export of this class of miRNAs is thought 
to occur via XPO5 (Figure 3). In addition, small RNAs which are derived from endogenous short 
hairpin (sh) RNAs and generated directly through transcription can similarly bypass 
DROSHA/DGCR8 processing (Figure 3) 51,54,55. This family of small RNAs carry a 
5`cap structure and are thought to be bound and exported by CRM1 (also known as XPO1) 
through the recruitment of phosphorylated adapter RNA export (PHAX) protein 56. Given that 
the interaction between PHAX and the canonical cap-binding-complex (CBC) is required for 
snRNA export via CRM1, the CBC might be similarly involved. 
In addition to the DROSHA/DGCR8-independent pathways, the DICER-independent pathway 
for miR-451 has been described, which instead uses the catalytic activity of argonaute-2 (AGO2) 
and poly(A)-specific ribonuclease (PARN) for further processing and trimming, respectively 
(Figure 3) 57–60. As well as group I pre-miRNA that have two nt 3`overhangs, group II pre-miRNA 
with only one nt 3`overhang can be generated. Group II pre-miRNAs involving most of the let-7 
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family in vertebrates use a TUTase-dependent pathway in which the terminal uridylyl transferases 
(TUTase) extent the 3`overhang by one nt following DICER processing (Figure 3) 61.  
 
Figure 3: Canonical and non-canonical miRNA processing and export pathways. 
Polymerase II transcribed miRNA sequences are found within introns or located at separate genomic loci and are produced as 
primary miRNAs (pri-miRNA) transcripts. Following the canonical miRNA pathway, the primary transcript is processed by 
DROSHA/DGCR8 generating a pre-miRNA transcript with a stem-loop structure. Subsequently, the pre-miRNA is bound by 
XPO5 in a RanGTP dependent manner and exported to the cytoplasm where GTP hydrolysis leads to the release of the 
pre-miRNA. On the cytoplasmic site, DICER further processes pre-miRNAs before the mature miRNA is integrated into the 
RISC complex and functions in RNA silencing. The DROSHA/DGCR8-independent pathway bypasses the DROSHA processing. 
The capped pre-mir-320 product is directly generated through transcription and exported to the cytoplasm bound by CRM1. 
Mirtron pre-miRNAs are a spliced product, debranched and trimmed before exported to the cytoplasm bound by XPO5. Group 
II pre-miRNAs follow the terminal uridylyl transferase (TUTase)-dependent export pathway. Pre-miRNA with a shorter 
3`overhang are produces and exported to the cytoplasm via XPO5. Due to the shorter overhangs pre-miRNA need to be 
monouridylated by TUTases before DICER processing in the cytoplasm. Following the DICER-independent pathway, 
pre-mir-451 transcript generated by DROSHA is possibly exported by the export receptor XPO5. The pre-miRNA is integrated 
into argonaute 2 (AGO2) without DICER processing. Followed AGO2-dependent splicing and poly(A)-specific ribonuclease 
PARN-dependent trimming the miRNA is integrated into the RISC complex. Pol II, RNA polymerase II. Schematic and figure 
legend were adapted from reference 51. 
The existence of all non-canonical pathways was shown by several studies, however, only 1% of 
conserved vertebral miRNAs are generated in a DROSHA/DGCR8- or DICER-independent 
manner and the majority of miRNAs follow the canonical pathway 51.  
1.1.2.3 Processing and export of rRNAs 
Ribosomes are RNA-containing particles needed in the process of protein production in the 
cytoplasm. Four ribosomal RNAs (28S rRNA, 5.8S rRNA, 5S rRNA and 18S rRNA) and more 
than 70 proteins build up the small (40S) and large (60S) subunit of the ribosome 5. Before 
executing their function in the cytoplasm, rRNAs are transcribed, processed and ribosomal 
subunits are erected in the nucleus and transported to the cytoplasm by several export receptors. 
This requires the transcription of precursor rRNA (pre-rRNA) and the synthesis and import of 
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ribosomal proteins. The imported ribosomal proteins are assembled with the pre-rRNAs in the 
nucleus. In the nucleo- and cytoplasm the pre-ribosomes transiently assemble with more than 150 
non-ribosomal proteins 62–64. Here, they undergo highly regulated and sophisticated mechanisms 
of processing, maturation and quality control before ribosomal ribonucleic particles (rRNPs) are 
bound by nuclear export factors in the nucleoplasm. The pre-40S and the pre-60S particles are 
exported through separate routes to the cytoplasm. The exact mechanism how the pre-40S 
subunit is transported to the cytoplasm is currently unknown, however, it was known that the 
karyopherin CRM1 mediates the export in a RanGTP-dependent manner and several pre-40S 
assembly factors and ribosomal proteins have been implicated to play a role in 40S particle export 
65–68. The export of pre-60S particles has been studied more extensively (mostly in yeast) and 
depends on the CRM1 export receptor and is therefore RanGTP-dependent 69–74. In addition, the 
export adaptor protein NMD3 that contains a NES signal is recruited to the export competent 
pre-60S particles before nuclear exit through the NPC 69–72,75,76. In the cytoplasm, RanGTP 
hydrolysis leads to the dissociation of CRM1 from the NMD3 adaptor. Binding of the cytoplasmic 
GTPase LSG1 releases NMD3 from the 60S subunit and subsequently the ribosomal protein 
RPL10 is bound 75,76. In Yeast, the heterodimer Mex67-Mtr2 (yeast homolog of NXF1-NXT1) 
was identified as additional export receptor that participate in the export of pre-60S and binds the 
60S subunit through a distinct interaction surface 77. In addition, ARX1 was implicated as an 
auxiliary export factor which is recruited to the export competent rRNP alongside with NMD3 
and MEX67-MTR2 75,78–80. In the cytoplasm, binding of REI1, which contributes to the terminal 
step in pre-60S biogenesis, releases ARX1 and its binding partner ALB1 from the 60S subunit 78,79. 
ARX1 was demonstrated to interact with the phenylalanine–glycine (FG) repeats of nucleoporins 
and thereby shuttling the export receptors through the nuclear pore 81. The human homolog of 
ARX1, PA2G4 has, in addition to its function as transcription factor, recently been implicated to 
play a role in 60S biogenesis by associating with pre-60S particles 82. In contrast to other RNA 
classes, the pre-60S particles can associate with several export receptors and thereby potentially 
increase efficiency of export.  
1.1.2.4 Processing and export of snRNAs 
Small nuclear RNAs can be divided into two classes, namely the Sm-class and Lsm-class snRNAs. 
All Sm-class snRNAs are synthesized by polymerase II and after full processing contain a 
5`trimethylguanosine cap, a 3`stem-loop and a Sm protein binding site 83,84. Except for U6 
snRNA, all synthesized snRNAs (U1, U2, U4, U5, U7, U11, and U12) belong to the Sm-class 
snRNAs. U6 snRNA, which is the only member of the Lsm-class snRNA, is characterized by its 
5`monomethylphosphate cap, a 3`stem-loop which is followed by a terminating uridine stretch 
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which forms the platform for Lsm protein binding. U6 snRNA is generated by polymerase III and 
does not leave the nucleus 85,86. Apart from U7 snRNP, which is involved in histone pre-mRNA 
3`end processing, all other snRNPs function in the spliceosome, which is a multifactorial 
machinery responsible for the removal of introns from pre-mRNAs in the nucleus 87.  
 
Figure 4: Biogenesis of Sm-class snRNAs. 
Sm-class small nuclear RNAs (snRNA) are transcribed by RNA polymerase II and the methylated cap structure (m7G) is bound by 
the cap-binding complex (CBC). Additional binding of the hyperphosphorylated form of the export adaptor (PHAX), the export 
receptor chromosome region maintenance 1 (CRM1) and RanGTP facilitates export to the cytoplasm. On the cytoplasmic site, 
GTP hydrolysis and dephosphorylation of PHAX drives the dissociation of all factors. Subsequently, the survival of neuron (SMN) 
complex binds snRNA by a specific sequence element and recruits a set of seven Sm proteins, which from the Sm-core RNP. 
Trimethylguanosine synthase 1 (TGS1) modifies the m7G cap with two additional methyl groups forming hypermethylated 
2,2,7-trimethylguanosine (TMG) cap structure. In addition, the 3`end is trimmed by an unknown exonuclease (Exo). The 
hypermethylated cap formation leads to the binding of the import complex including the import adaptor snurportin-1 (SPN) and 
the import receptor importin-β (Imp-β) leading to re-import to the nucleus. On nuclear site, the re-imported snRNP complex is 
targeted to cajal bodies (CB) for further snRNP maturation before it functions in mRNA splicing. Schematic and figure legend 
were adapted from reference 83. 
Before functioning in the spliceosome, Sm-class snRNAs are exported to the cytoplasm to undergo 
maturation and it has been suggested that as part of a quality control mechanism the cytoplasmic 
phase might be required to prevent nuclear accumulation of dysfunctional snRNAs (Figure 4) 88. 
Following transcription by polymerase II, a N7-methylguanosine cap (see chapter 1.1.3.1) is 
added to the 5`end of snRNAs and the 3`end is processed in the nucleus, however, snRNAs do 
not get the typical poly(A) tail as found on polymerase II transcripts like miRNAs and mRNAs  
89–92. The 5`cap structure is co-transcriptionally bound by the canonical CBC and the 
NES-containing adaptor protein PHAX 89,93,94. Upon phosphorylation of PHAX, CRM1 is 
recruited to the snRNA and in turn, the snRNA is recruited in a RanGTP-dependent manner. 
After arrival in the cytoplasm, the snRNA is released by the hydrolysis of GTP and the 
dephosphorylation of PHAX (Figure 4). Hypophosphorylated PHAX is re-imported to the nucleus 
by the help of importin-ß 95. The cytoplasmic snRNA is then assembled with a ring of seven 
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different Sm proteins, which is enabled by the binding of the survival of motor neuron (SMN) 
complex 88. Following the binding of the Sm proteins, the monomethylated 5`cap becomes 
trimethylated (TMG) by the activity of the trimethylguanosine synthase (TGS1) and the 3`end 
sequence is trimmed by an exonuclease (Figure 4) 96,97. The compositions of the snRNP, consisting 
of the TMG cap and the Sm ring, provides the snRNA with two NLS for re-import to the nucleus. 
The two NLS are bound by different adaptor proteins 98,99: The TMG cap NLS is recognized by 
the import adaptor called snurportin-1, whereas, in case of Sm core NLS the SMN (or a 
sub-complex) serves as the import adaptor. Both adaptors associate with the import receptor 
importin-ß and subsequently initiate the translocation of the snRNP to the nucleus 100. After 
additional snRNP maturation steps in the cajal bodies of the nucleus, the snRNPs together with a 
variety of additional splicing factors build up the spliceosome and function in the removal of 
introns 101–106. 
1.1.3 Insights from mRNA: from pre-mRNA processing to export of mature mRNPs 
1.1.3.1 The RNA cap structure 
The RNA cap structure is the first modification that is co-transcriptionally added to the 5`end of 
newly generated polymerase II transcripts (Figure 5a) 107. The phosphorylation state of the 
C-terminal domain (CTD) of polymerase II, which is composed of 52 heptapeptide repeats 
(YSPTSPS), drives the timing of RNA modifications. Following transcription initiation, CTD 
serine 5 becomes phosphorylated which in turn activates the process of 5`end RNA capping by a 
transcript length of ~20-30 nt 108,109. The enzymatic activity of three specified enzymes is required 
for the addition of an N7-methylguanosine to link to the first nucleotide by a 5`-5`triphosphate 
linkage (Figure 5b) 110.  
The first step, which removes the γ-phosphate from the 5`triphosphate and generates a 
di-phosphate residue, is executed by the RNA triphosphatase (RTPase). Subsequently, the RNA 
guanylyltransferase (GTase) adds a guanosine monophosphate (Gp) to the RNA 5`diphosphate. 
Finally, the guanine-N7 methyltransferase (N7MTase) modifies the N7 amine of the guanine with 
a methyl group. Unlike yeast, metazoan RTPase and GTase are subunits of one protein called 
capping enzyme (CE) or RNA guanylyltransferase and 5`triphosphatase (RNGTT) which is 
suggested to perform a more efficient and coordinated reaction 110,111.  
The final cap structure builds up a unique feature that not only protects the RNA against 
5`-3`degradation but also triggers fundamental events in the biogenesis of polymerase II 
transcripts by the association with cap-binding proteins such as the CBC in the nucleus and the 
eukaryotic translation initiation factor 4E (eIF4E) in the cytoplasm. 
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Figure 5: RNA cap structure and the capping mechanism. 
(a) The RNA cap consists of a N7-methylguanosine linked by a 5`-5`triphosphate linkage to the 5`nucleoside of the RNA. Three 
methyl modification can occur at the 5`end of the RNA. Methylation of the N7 position of the guanosine is referred as Cap 0 
(green), methylation of the O2 position of the first and second transcribed nucleotide are referred to Cap 1 and Cap 2 (red), 
respectively. (b) The RNA capping reaction generating Cap 0 structures is performed by the action of three enzymes. First, the 
reaction of RNA triphosphatase (RTPase) removes the γ-phosphate of the nascent RNA (pppNp-RNA) and generates disphosphate 
RNA (ppNp-RNA) and inorganic phosphate (Pi). The second enzyme, the guanylyltransferase (GTase), adds the α-phosphate of 
GTP (Gppp) to the disphosphate RNA template via a covalent enzyme-guanylate intermediate (Gp–GTase) releasing 
pyrophosphate (PPi) and forming GpppNp-RNA. In the last step, the guanine-N7 methyltransferase (N7MTase) transfers the 
methyl group from S-adenosyl-L-methionine (AdoMet) to the guanine and generates N7-methyl-GpppNp-RNA 
(m7GpppNp-RNA; Cap 0) releasing S-adenosyl-L-homocysteine (AdoHcy) as a by-product. Cap 1 RNA structure is formed by 
the action of the AdoMet-dependent 2′O-methyltransferase (2′OMTase). Similar to N7MTase, 2′OMTase transfers a methyl group 
from AdoMet to the O2 position of the first ribose releasing AdoHcy forming the Cap 1 RNA structure (m7GpppNmp). Schematic 
and figure legend were adapted from reference 107. 
In the nucleus, the CBC instantly binds to the newly synthesized cap structure and orchestrates 
the recruitment and binding of additional factors that successively lead to the activation of 
processes such as pre-mRNA splicing and 3`end processing as well as transcription termination, 
exosomal degradation, RNA export, translation initiation and mRNA pseudo-circulation 88,89. In 
addition to the N7-guanosine methylation, metazoan polymerase II transcripts are methylated at 
the O2 position of the first (and second) transcribed nucleotide, which was reported to be 
fundamental for the discrimination of self and foreign RNA (e.g. invading viral RNA) by the innate 
immune system (see chapter 1.2.1) 113.  
In the following section, the mechanisms and factors involved in successful mRNA processing and 
export from the nucleus are described in more detail. 
1.1.3.2 Processing and assembly of export-competent mRNPs 
Capping of the 5`end of nascent polymerase II transcripts is the hallmark of successful transcription 
initiation and a prerequisite for elongation of transcripts. Elongated transcripts are bound by 
heterogeneous nuclear ribonucleoprotein particles (hnRNPs) which are thought to discriminate 
mRNA from snRNA 114. RNAs longer than 200-300 nt preferentially bind hnRNPs which 
displaces PHAX, the snRNA export adaptor, from the transcript (Figure 6a) 115. hnRNPs 
predominantly associate with introns in a repeated fashion and wrap ~150-250 nt around its 
tetrameric core 116–118. These findings suggested that hnRNPs scaffold pre-mRNA during 
transcription and act as chaperons and/or regulators 119. Additionally, one can assume that 
hnRNPs are able to package RNA similar to histones that bundle DNA and form nucleosomes 120. 
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Nascent messenger ribonucleoprotein particles (mRNPs) contain hnRNPs as well as spliceosomal 
components and both protein complexes are assembled co-transcriptionally on mRNA suggesting 
that hnRNP packaging has a role in mRNA splicing (Figure 6b)116,120–123. Packaging could bring 
distant regions into close proximity enabling cis-interactions such as constitutive or alternative 
splicing (Figure 6c, d).  
 
Figure 6: Co-transcriptional mRNA packaging. 
(a) Polymerase II transcripts are packed during transcription by heterogeneous nuclear ribonucleoprotein C (hnRNPC) which act 
as a kind of 'molecular ruler' to sort the transcripts before export to the cytoplasm. This sorting is based on the binding of either 
hnRNPC or the phosphorylated adaptor for RNA export (PHAX). PHAX binds small nuclear RNAs (snRNA) up to a length of 
~200-300 nucleotides by the interaction with the cap-binding complex (CBC). snRNA are escorted to the cytoplasm binding to 
chromosomal region maintenance protein 1 (CRM1) (right branch). Transcripts longer than ~200-300 nucleotides are 
subsequently bound by the tetrameric hnRNPC complex (left branch), which inhibits the association of PHAX. Transcripts 
wrapped around the tetrameric hnRNPC complex are targeted to the nuclear RNA export factor 1 (NXF1) export pathway. (b) 
Transcription: The tetrameric hnRNP complex is assembled co-transcriptionally on mRNA and this packaging is suggested to have 
a role in mRNA splicing. (c) Constitutive splicing: Packaging by the hnRNP tetramer holds consecutive exons in close proximity 
and ensures correct ordered splicing. (d) Alternative splicing: Through packaging by the tetrameric hnRNP complex strong splice 
sites or alternative exons could be hided and thereby exon skipping could be promoted. Additionally, weak splice sites could be 
exposed to facilitate exon inclusion. m7G, 7-methylguanosine. Schematic and figure legend were adapted from reference 120.  
The process of splicing which removes introns from pre-mRNA is initiated by the phosphorylation 
of CTD serine 2 108. Splicing is catalyzed by the spliceosome that assembles de novo on each 
pre-mRNA transcript during transcription and is composed of five spliceosomal small nuclear 
ribonucleoprotein particles (snRNPs) associated with a large number of additional proteins 122. In 
pre-mRNA splicing, the importance of the m7G (N7-methylguanosine) and the binding of the 
CBC was demonstrated in several studies. The initial study using Xenopus leavis oocytes showed 
that micro-injected transcripts need the m7G structure to efficiently splice 5´proximal introns 124. 
Another study by Izaurralde et al. revealed the importance of the CBC for efficient mRNA splicing 
by microinjecting transcripts in nuclear cap-binding protein 2 (NCBP2) immuno-depleted Xenopus 
leavis oocytes that resulted in decreased splicing efficiency 94. Treating total or nuclear HeLa 
extracts with uncapped or m7G -capped transcripts confirmed that the m7G group is essential for 
efficient splicing in mammalian cells 125–129. Additionally, inhibition of the CBC in HeLa cells 
resulted in altered mRNA splicing and decreased recruitment of U1 snRNP to the 5`splice site of 
5`proximal introns 125,130. Recently, it was shown that the spliceosome assembly depends on the 
interaction of the CBC with protein components of the U4/U6.U5 tri-snRNP complex 131. 
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Additionally, m7G and the CBC is not only required for removal of 5`proximal introns but also 
for splicing of downstream introns 131,132. However, it is still unclear to what extent the CBC is 
required for downstream splicing on a transcriptome wide level.  
In the wake of splicing, the exon-junction complex (EJC) is deposited ~20-24 nt upstream of each 
exon-exon junction 133,134. The EJC couples splicing events to post-transcriptional steps such as 
mRNA export and surveillance. The best-studied surveillance mechanism is the 
nonsense-mediated decay (NMD) pathway, which detects premature termination codons in the 
pioneer round of translation sensing possible downstream EJCs and removing these mRNAs from 
the translational pool 135. Early in splicing, the EJC core proteins EIF4A3, MAGOH and RBM8A 
are recruited transiently to the spliceosome and build up the trimeric pre-EJC showing that EJC 
assembly and pre-mRNA splicing are two tightly linked processes (Figure 7) 122. In this regard, 
the association of EIF4A3 and the pre-mRNA-splicing factor CWC22 homolog (CWC22), which 
is an abundant and essential factor of the spliceosome is to date the only identified direct 
interaction of the spliceosome and the pre-EJC 136–141. It was shown that splicing efficiency as well 
as EJC assembly is impaired when CWC22 is missing emphasizing the necessity of the interaction 
of CWC22 and EIF4A3 for EJC assembly during splicing 138,139. Following splicing termination by 
exon ligation and release of the spliceosome, the trimeric pre-EJC is joined by barentsz (BTZ; 
also known as MLN51 or CASC3) protein to form the mature, tetrameric EJC (Figure 7) 142. 
CWC22 keeps EIF4A3 in an open state, however, it is not known how the transition of the open 
to the closed state, where CWC22 releases EIF4A3, happens 143,144. In its closed form EIF4A3 can 
bind RNA and ATP and it was shown that the three other core proteins are required to stably 
keep EIF4A3 in its closed RNA-bound form and to prevent release of hydrolyzed ATP 144,145. The 
EJC clamps on the RNA in a sequence-independent mode which was revealed by the crystal 
structure of the core EJC bound to RNA 143,146. EIF4A3 RNA-binding is established mainly through 
the binding of the ribose-phosphate backbone and not by the association of specific bases. Studies 
combining biochemical and mass spectrometry based analysis showed that more than 30 proteins 
can be co-purified with the core EJC 147–149. The four core EJC proteins employ a large number of 
transiently interacting proteins to fulfill the demanding varying role in post-transcriptional 
processes such as export of mature mRNA to the cytoplasm, initiation of translation and quality 
control mechanisms. 
The EJC-associated proteins can be classified as components of outer shell and transiently 
interacting proteins 149–151. The outer shell is composed of ALYREF, PNN, ACIN1, RNPS1 and 
SAP18 from which ACIN1/RNPS1/SAP18 form the apoptosis and splicing associated protein 
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(ASAP) complex and PNN/RNPS1/SAP18 build up an alternative complex named PSAP 149,152–
154. It is currently unknown to which extent the function of the two complexes overlap or how 
they are recruited to the EJC. It is speculated that the ASAP associates with the EJC during 
deposition on mRNAs indicated by co-purification with the spliceosome and the EJC and 
localization to the nucleus 149,152,155,156. A more transient interaction with the EJC was found for 
UAP56, NXF1/NXT1 (also known as TAP/p15) as well as SRRM1, UPF1, UPF2 and UPF3a/b. 
 
Figure 7: Assembly of the exon-junction complex. 
During splicing of pre-mRNAs in the nucleus, the exon-junction complex (EJC) is assembled on mRNAs. One essential factor of 
the spliceosome, namely CWC22, recruits the core EJC component EIF4A3 to the RNA. The stable MAGOH/RBM8A 
heterodimer is recruited to the RNA in a separate so far unknown mechanism. The spliceosome releases the spliced mRNA on 
which the EJC is deposited on exon-exon junctions. After release from the spliceosome, barentsz (BTZ), the fourth EJC subunit, 
binds to the EJC core. Three potential outcomes of splicing and EJC assembly have been described: (1) binding of a canonical EJC 
at a position 20-24 nucleotides (nt) upstream of the exon–exon junction, (2) binding of a non-canonical EJC at a position different 
from the canonical binding site, or (3) absence of an EJC at the canonical binding site. Schematic and figure legend were adapted 
from reference 156. 
The EJC core, as well as its interacting proteins, participate in various pathways such as 
splicing/alternative splicing (SRRM1, SAP18, RNPS1, ACIN1, PNN), mRNA export (UAP56, 
ALYREF, NXF1/NXT1) and NMD (UPF1, UPF2, UPF3a/b) and thereby effectively connect 
these pathways 134,153,157–170. Splicing was reported to promote transcript kinetics and abundance 
in the cytoplasm, demonstrating a direct dependence of splicing on mRNA export 171. 
Additionally, the export factors ALYREF (also known as THOC4) and UAP56 are recruited to 
spliced mRNAs via the EJC linking pre-mRNA splicing to mRNA export 165,170,172. ALYREF and 
UAP56 are EJC-associated proteins that together with THOC1, THOC2, THOC3, THOC5, 
THOC6, THOC7 form the transcription-export 1 (TREX-1) complex that couples transcription 
to mRNA export 165,172–174. More recently, researchers identified SARNP, POLDIP3, ZC3H11A, 
CHTOP, DDX39A, UlF ,ERH and LUZP4 as putative new TREX-1 subunits 175–180. Cheng et al. 
showed in 2006 that TREX-1 complex is recruited to the 5`end of the mRNA in a splicing- and 
cap-dependent manner 181. This recruitment is based on the interaction between ALYREF and the 
nuclear cap-binding protein 1 (NCBP1; CBC subunit). The interaction of ALYREF with TREX-1 
complex is dependent on ATP-binding of UAP56 175. The mRNA export receptor NXF1 is 
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recruited to the mRNA through its interaction with ALYREF and THOC5 182. This interaction 
drives NXF1 into its open conformation revealing its RNA recognition motif (RRM) and 
subsequently allowing the direct binding of mRNA (Figure 8). In turn, the binding activity of 
ALYREF to the mRNA is decreased implicating that mRNA is handed from ALYREF to the export 
receptor NXF1 at this step 183. This highlights the important role of ALYREF in mRNA biogenesis, 
through coupling the EJC and TREX complex with mRNA export. Interestingly, knockdown of 
single TREX components normally results in a moderate export block, whereas double 
knockdown reveals a severe export block. In contrast, single knockdown in yeast already results 
in a rapid mRNA export block 174. This suggests that metazoans have developed a mechanism to 
ensure processing and export even if one export player is downregulated. 
To complete processing of mRNAs, the 3`end is cleaved and subsequently polyadenylated to 
define the end of the mRNA. Consequently, mRNAs are released from the transcription 
machinery and are targeted to the export machinery 120. The cleavage and polyadenylation (CPA) 
complex is recruited to the poly(A) signal (PAS) in the 3`UTR of pre-mRNA by interacting with 
serine 2 phosphorylated CTD and RNA binding domains that specifically bind the PAS 184,185. The 
poly(A) polymerase (PAP) adds the poly(A) tail which is rapidly bound by poly(A)-binding 
proteins (PABPs) increasing the processivity of PAPs. The nuclear poly(A)-binding protein 
PABPN1 is thought to act as “molecular ruler” by determining the length of the poly(A) tail 186. 
Studies using electron microscopy revealed that the poly(A) tail is coated by many PABPN1 
generating a spherical particle with ~250 accompanied nucleotides 186. As expected, genome-wide 
studies have shown that loss of PABPN1 results in overall shortening of 3`UTRs 186. In addition, 
PABPN1 is essential for bulk mRNA export and shuttles between the nucleus and the cytoplasm 
186. Interestingly, the CPA complex is associated with ALYREF, CLIP, DDX39A/B and PCF11 
and it was hypothesized that these proteins are involved in the PAS selection 187. In addition, 
THOC5 was found to interact with the 3`end processing factors CPSF2 and CPSF6 suggesting to 
be involved in PAS choice for specific genes 188,189. CPSF6 is a positive regulator of alternative 
polyadenylation (APA) and known to be important in selecting alternative poly(A) sites 186. To 
date, it is believed that APA and mRNA splicing are connected in some way, however, it is not 
known how APA and mRNA export are linked 190,191. It was demonstrated that U1 snRNP could 
suppress APA binding to pre-mRNAs introns or non-canonical PASs in the 3`UTRs and thereby 
shielding premature cleavage and polyadenylation sites 192,193. Moreover, CPSF6 has recently been 
shown to shuttle to the nucleus and associate with the export receptor NXF1 indicating a potential 
link between APA and mRNA export 194.  
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Overall, the coupling of 3`end processing and mRNA export is needed at least for canonical 
polyadenylation to enable the release of fully processed transcripts from the transcription 
machinery and ensure efficient targeting to the export machinery. 
1.1.3.3 Routes of mRNA export 
After the three main processing steps of mRNA capping, splicing and 3`end processing, correctly 
processed mRNPs are targeted for export and translocation through the NPC to the cytoplasm. 
In all cases, the transport of macromolecules like mRNA needs energy to shuffle through the NPC 
to the cytoplasm. In case of bulk mRNA, this energy is generated by the proteins GLE1, DDX19 
(also known as DBP5) and inositol hexakisphosphat (IP6) facilitated by an ATP cycle (Figure 8). 
The translocation through the nuclear pore can be divided into three steps characterized by the 
docking of the mRNA onto the nuclear basket, the transit through the central channel and the 
release of the mRNA into the cytoplasm 2. The export receptor NXF1 bound to NXT1 is the most 
common export receptor for bulk mRNA export. Through the recruitment of multiple adaptor 
proteins NXF1 can increase its affinity for its target RNAs. It was also shown that CRM1 can 
associate with adaptor proteins to bind specific mRNAs and utilize their export to the cytoplasm. 
In the following paragraphs, the different mRNA export routes with their export receptors, 
adaptors and their selectivity for targets are described in more detail.  
NXF1 mediated export of bulk mRNAs 
The first identification of NXF1 was as an export receptor for Mason Pfizer monkey virus where 
NXF1 interacts with the constitutive transport element (CTE) of viral RNAs and exports them to 
the cytoplasm 195–197. Only later, studies revealed the fundamental role of NXF1 in bulk mRNA 
export 196,198. NXF1 is crucial for cell proliferation and depletion of NXF1 leads to retention of 
polyadenylated RNA in the nucleus. NXF1 is composed of multiple domains, namely the 
arginine-rich RNA-binding domain (RBD), adjacent ψRRM, leucine-rich repeat (LRR), NTF2-
like (NTLF2L) and ubiquitin-associated (UBA) domain 2. THOC5 binds the NTF2L domain of 
NXF1 and links the association of NXF1 with ALYREF 183,199–201. NXF1 binds non-specifically to 
RNA via its N-terminal RDB domain, however, once ALYREF is bound to NXF1, the 
RNA-binding affinity of NXF1 is enhanced. Upon ALYREF binding, NXF1 exhibits its open form 
resulting in the transfer of RNA from ALYREF to NXF1 (Figure 8) 183. NXF1, in its open and 
mRNA-locked form, escorts the mRNP complexes to the nuclear pore and translocates the 
mRNPs through the nuclear pore by interacting with nucleoporins via its NTF2L and UBA 
domains (Figure 8). Simultaneous depletion of ALYREF and THOC5 reduces the amount of 
NXF1 bound to mRNA highlighting the major role of TREX-1 complex to recruit NXF1 to 
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mRNAs 182. In addition, by recruiting NXF1 to the mRNA cargo via TREX-1 it is ensured that 
only fully processed mRNAs are targeted for export.  
 
Figure 8: NXF1-dependent mRNA export. 
During NXF1-dependent mRNA export, the transcription-export 1 (TREX-1) complex consisting of ALYREF, UAP56 and the 
THO complex subunits assembles on the spliced mRNA. In turn, the NXF1/NXT1 heterodimer is recruited to the mRNA via 
interactions with TREX-1 complex subunits. Bound by the open form of NXF1, mRNPs are translocated to the cytoplasm trough 
interaction with subunits of the nuclear pore complex (NPC). CBC, cap-binding complex; INM, inner nuclear membrane; IP6, 
Inositol hexakiphosphate ;ONM, outer nuclear membrane. Schematic and figure legend were adapted from reference 202. 
Transcription and processing is thought to take place in nuclear speckles in the nucleus, which 
means that the mRNP complexes need to travel through the nucleoplasm to reach and dock onto 
the NPC. In this context, the TREX-2 complex was proposed to assist mRNPs on their way to 
the nuclear basket 203,204. TREX-2 is composed of GANP, ENY2, CETN2/CETN3, PCID2 and 
DSS1. GANP directly interacts with NXF1 and scaffolds the other members of the TREX-2 
complex to the mRNA 205. A fraction of TREX-2 is located within the nucleoplasm, however, the 
main fraction is located at the NPC 203,204,206. ENY2 and GANP were shown to also interact with 
RNA polymerase II and thereby potentially facilitating the recruitment of TREX-2 to a subset of 
specific genes 204. TREX-2 was shown to transfer mRNA to NXF1. However, the exact 
mechanism is not well characterized. In addition, it is still unclear whether TREX-2 is a general 
export complex or utilizes export of specific transcripts. Studies demonstrated that GANP specific 
transcripts were exported faster than others suggesting an accelerated pathway enabled by GANP 
for specific transcripts 207. In addition, GANP depletion experiments revealed that GANP is 
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needed for the export of transcripts involved in gene expression (e.g. mRNA processing, splicing 
and ribosome biogenesis) 207. These GANP-specific transcripts have in average shorter half-lives 
and are expressed above-average compared to GANP-independent transcripts. This suggests the 
potential of GANP to institute an accelerated export route for specific transcripts, which is needed 
to rapidly adapt to internal or external stimuli. 
The transition through the nuclear pore is a better characterized process. After docking to the 
nuclear basket, the traveling through the nuclear pore occurs via series of interactions with FG 
Nups 2. First, RAE1 interacts with NXF1 and it was proposed that RAE1 delivers NXF1/mRNPs 
to Nup98 208,209. Inside the channel, NXF1 interacts with Nup62, however, the exact mechanism 
how NXF1/mRNPs travel through the central channel is still unclear. Nonetheless, recent studies 
have revealed insights into the kinetics of mRNPs translocation from the nuclear site of 
transcription to the cytoplasmic site of translation. The transit through the NPC is a relatively 
rapid process which takes less than 500 ms, whereas, the diffusion of mRNPs from transcription 
and processing speckles can take up to several minutes and is seen as the rate-limiting step in this 
pathway 210–212. Surprisingly, only 25-35% of initially docked mRNPs are successfully transferred 
to the cytoplasm 210–212. From their place of transcription and processing, mRNPs transit trough 
regions of interchromatin space or zones of heterchromatin exclusions in the nucleoplasm, which 
build up a channel-like structure that enable the directed diffusion of mRNPs to the NPC 213–215. 
The filamentous NPC-associated nucleoprotein TPR is thought to from such channels since 
depletion of TPR resulted in heterchromatin-covered NPCs 216,217. Interestingly, TREX-2 
associates with TPR at the nuclear basket, which could result in more efficient diffusion of 
TREX-2 associated mRNPs to the NPCs and a faster export of TREX-2 dependent transcripts 
206,207. 
Passaged the nuclear pore channel, mRNAs associate with fibrils on the cytoplasmic site of the 
NPC mainly comprised of Nup358/RanBP2 218. RanBP2 associates with the NPCs via Nup88 and 
Nup214 and can additionally interact with NXF1, RanGAP and Ran 218–220. DDX19 and GLE1 
enable the release of mRNAs to the cytoplasm in an ATP-dependent manner (Figure 8). In that 
manner, GLE1 associates with the signaling molecule IP6 stimulating the binding of DDX19 to the 
mRNA and triggering mRNA release by ATP hydrolysis 2,221. The release and remodeling of the 
mRNA in the cytoplasm leaves free export factors that are recycled back to the nucleus. mRNAs 
are then transferred to the translational machinery where they undergo further remodeling. For 
instance, the CBC complex is replaced after the pioneered round of translation by the cytoplasmic 
cap-binding protein eIF4E allowing steady-state translation.  
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NXF1 mediated export of specific mRNA transcripts  
In addition to the above described mechanisms, transcript specificity can be introduced by 
changing the composition of the mRNPs. In this manner, NXF1 can associate with different 
adaptor complexes to allow binding of specific transcripts (Figure 9). For instance, components 
of the TREX complex were demonstrated to be involved in the export of specific transcripts. 
THOC5 was shown to be dispensable for bulk mRNA, however, in association with ALYREF 
needed for the export of HSP70 mRNAs which are crucial in heat-shock responses (Figure 9a) 222. 
THOC5 together with THOC2 controls mRNA export transcripts involved in pluripotency, e.g. 
Nanog and Sox2, and thereby contributing to embryonic stem cell self-renewal and differentiation 
(Figure 9a) 223. Interestingly, THOC5 is reduced during differentiation leading to decreased 
interaction of THOC2 with these transcripts, which results in reduced export of transcripts 
required for pluripotency.  
The alternative mRNA export (ALREX) pathway including CIP29, DDX39 and NXF1 exports a 
subset of transcripts involved in mitosis 180. Loss of DDX39 results in altered Birc5 and Prc1 
mRNA export leading to mitotic defects like chromosome arm resolution defects and failure of 
cytokinesis. CHTOP is another TREX component, which can compete with ALYREF for NXF1 
binding and thus may modulate the export of specific transcripts 180. The newly identified 
TREX-component LUZP4, which associates with UAP56 and NXF1 was shown to be upregulated 
in cancer cells, indicating a dysregulation in mRNA export 180. LUZP4 was suggested to be 
involved in export of a subset of transcripts needed for melanoma cells proliferation, however, 
the subset of transcripts regulated by LUZP4 was thus far not investigated in detail. 
Organism-wise, it is possible that cell-type specific TREX complexes exist and are involved in 
export of specific transcripts.  
Besides TREX components, SR proteins can also compete with ALYREF for NXF1 binding. In 
that manner, SRSF1, SRSF3 and SRSF7 were identified to interact with NXF1 and export specific 
transcripts 224. SRSF3 and SRSF7 recognize the intronless transport element (ITE), a 
22-nucleotide motif in histone H2A mRNA, and target these transcripts to export via NXF1. 
Following this finding, SRSF3 and SRSF7 were depending on their phosphorylation status 
demonstrated to be involved in the transport of spliced transcripts to the cytoplasm. In its 
hyperphosphorylated form, SRSF3 associates with mRNA prior to splicing. After splicing SRSF3 
becomes hypophosphorylated and thereby targets its transcripts to NXF1-dependent export 225,226. 
In the cytoplasm, re-phosphorylation occurs leading to release of NXF1 and mRNA.  
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Figure 9: Selective mRNA export pathways. 
(a) Selective mRNA export for transcripts involved in pluripotency and heat-shock. Selectively is driven by the control of THOC5 
and THOC2. (b) Genome replication and repair transcripts are exported selectively by the binding of ALYREF and the enzyme 
inositol polyphosphate multikinase (IPMK) together with IP6. (c) Hu-antigen R (HuR) in association with pp32 and APRIL binds 
to a subset of transcripts and exports these transcripts to the cytoplasm in a CRM1-dependent manner. Transcripts were suggested 
to be involved in transcription, cancer as well as in immune responses. (d) NXF3 exports a so far unknown subset of mRNAs in 
a CRM1-dependent manner. (e) Transcripts involved in proliferation, survival, metastasis and invasion are exported in a 
CRM1-dependend manner bound by eIF4E and LRPPRC, which binds to the 4E-sensitive element (4ESE) in the 3`UTR. 
CRM1-dependent pathways require the binding of RanGTP in the nucleus and release of the mRNA in the cytoplasm is driven by 
GTP hydrolysis. CRM1, chromosome region maintenance 1; IPMK, inositol polyphosphate multikinase; LRPPRC, leucine-rich 
PPR motif-containing protein; NPC, nuclear pore complex. Schematic and figure legend were adapted from reference 202,221. 
Another selective mRNA pathway including export of transcripts required for genome replication 
and repair, e.g. Rad51, Chek1 and Fancd2, depends on the binding of ALYREF and the enzyme 
inositol polyphosphate multikinase (IPMK) 227. IPMK is required for the binding of ALYREF to its 
target transcript in which a sequence motif in the 3`UTR permits ALYREF binding (Figure 9b).  
Adaptor proteins mostly preserve specificity by defined sequence elements in the RNA. For 
example, RNAs containing the RNA transport element (RTE) consisting of a minimum of four 
internal stem loops are bound by RBM15 and targeted for translocation via NXF1 228,229. In some 
cases, NXF1 can directly bind RNAs by interacting with specific RNA elements. One of such 
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element is CTE, which was first identified in Mason Pfizer monkey virus to be important to export 
viral transcripts in a NXF1-dependent manner 196,198,230. RNA containing the signal 
sequence-coding element (SSCR) present on transcripts involved in secretion can also be exported 
in a NXF1-dependent manner 231,232. SSCR was also found to act as an export sequence for 
transcripts lacking introns or functional caps being NXF1-dependent but TREX-independent.  
Interestingly, Nups can also impact export of specific transcripts. In this context, Nup96 was 
shown to be involved in the export of transcripts encoding cell cycle and immune responses 
regulators, namely ß2-microglobulin, CDK6, MHCI and MHCII 233,234.  
CRM1 mediated export of specific mRNA transcripts  
As described in chapter 1.1.2, CRM1 is the main export receptor for snRNA. Since CRM1 is 
unable to directly bind RNA, it associates with export adaptors containing NES. It was 
demonstrated that a subset of mRNA can be exported using the RanGTP-dependent CRM1 
export pathway. 
One subset of mRNA is selected and exported via CRM1 by the interaction of human antigen R 
(HuR; also known as ELAVL1) protein with AU-rich elements (AREs) in the 3`UTR of the RNA 
encoding for oncoproteins, cytokines and transcription proteins 235–237. In addition to HuR, pp32 
and APRIL also associate with CRM1 to export these mRNAs (Figure 9c) 238. Studies have shown 
that not all CRM1-dependent transcripts rely on the association with HuR. For example, human 
type I interferon α is exported in a CRM1-dependent manner but independent of HuR binding 
239,240. Another adapter associating with CRM1 is NXF3 241. NXF3 belongs to the NXF protein 
family but is unable to associate with Nups, which leads to the association and export utilizing 
CRM1 as export receptor (Figure 9d). Currently, specific sequence elements and the exact 
mechanism of this pathway is unknown and needs to be further investigated. 
Another selective pathways using CRM1 as export receptor is dependent on the binding of the 
translation initiation factor eIF4E with transcripts involved in proliferation, survival, metastasis 
and invasion (Figure 9e). The eIF4E-dependent transcripts contain an approximately 50 
nucleotide long secondary structure element in their 3`UTR known as 4E-sensitive element 
(4ESE) 242. The association of eIF4E with the sequence element is linked by the direct interaction 
of the export adaptor protein LRPPRPC with 4ESE and eIF4E 243. The dependency of CRM1 for 
the export of this subset of genes was demonstrated by the use of the CRM1 inhibitor leptomycin 
B which resulted in the inhibition of eIF4E-dependent mRNA export242. Moreover, depletion of 
NXF1 did not affect export of eIF4E-depenedent transcripts. Interestingly, RIP-seq experiments 
showed that eIF4E can bind to around 2300 transcripts in the nucleus suggesting a broader 
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importance of CRM1 and eIF4E in the export of mRNAs 244. To date, it is known that factors like 
UAP56, hnRNPA1 and DDX3 are common to both, the NXF1 and eIF4E/CRM1 export 
pathways, whereas, factors like NXF1, ALYREF and CBC are not required for mRNA export via 
eIF4E/CRM1 243. Since 4ESE-containing mRNAs have long 3`UTRs with several export sequence 
motifs and are targets for both, bulk and eIF4E-depedent export, it can be hypothesized that the 
eIF4E/CRM1 competes with bulk mRNA export factors to boost export of specific transcripts 2. 
Studies propose that RanBP2 reduces release and/or recycling of eIF4E-depentent export factors 
to the nucleus 245,246. To overcome this inhibitory mechanism and enhance export, eIF4E can 
indirectly suppress RanBP2 function. This might be important in a wide range of cancers since 
eIF4E is upregulated in these tissues influencing their proliferative capacity by promoting 
eIF4E/CRM1 export pathway 245,246. 
Other pathways 
Two other mRNA export pathways were described to transport mRNPs to the cytoplasm, namely 
nuclear envelope budding and NPC enlargement 2. The first mechanism was shown to happen 
during synapse development and enables the export of large mRNP granules by budding out the 
NE similar to the mechanism of nuclear egress used by herpes viruses 247–251. Specifically, 
recruitment of the atypical protein kinase C to the nuclear envelope leads to phosphorylation of 
the nuclear lamina, which prompts the invagination of the inner nuclear membrane into the NE 
lumen. Consequently, fusion with the outer nuclear membrane enables the delivery of large 
mRNPs into the cytoplasm 2. The second mechanism of envelope enlargement was first seen 
during influenza A virus infection (IAV) 252. It was shown that viral infection could enlarge the 
nuclear pores in a caspase-dependent manner to approximately 50 nm (normally approximately 
30 nm) facilitating the translocation of large protein-RNA complexes 253–255. Viral mRNPs are 
usually exported in a CRM1-dependent manner bound by the viral export adaptor protein 
nucleoprotein (NP). However, at late stages of infection the enlargement of the nuclear pore 
occurs, which enables the passive diffusion of proteins with a size of ~125 kDa and viral RNPs. 
Whether this mechanism plays a role to host mRNP translocation needs further investigation 254. 
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1.2 RNA export during viral infection 
Exporting mRNAs is a critical step in the lifetime of a cell to regulate and maintain cellular 
functions. However, the nucleo-cytoplasmic transport of RNA becomes even more important 
when the cell encounters environmental challenges. This includes the appropriate response to 
pathogens such as viruses. During a viral infection, the invading pathogen is recognized by 
cytoplasmic or endosomal pattern recognition receptors (PRR) via pathogen associated molecular 
patterns (PAMPs). Following recognition of the virus, the cell initiates innate immune responses 
by expressing cytokines and chemokines that establish a pro-inflammatory and anti-proliferative 
antiviral state. This process involves the expression of type I (IFNα, IFNβ), II (IFNγ), III (IFNλ) 
interferons (IFN) to defend viral infection by initiating the transcription of mRNAs that encode 
antiviral factors.  
1.2.1 Discrimination between self and non-self RNA 
The molecular basis of discriminating host appearance from foreign PAMPs concerning the 
recognition of invading foreign RNA during virus infection by PRRs was the topic of a review 
included in the special issue “Discrimination of Viral and Self Nucleic Acids and IFN Signature Diseases” 
of the Journal of Interferon & Cytokine Research. I wrote the review together with 
Beatrice T. Laudenbach und Andreas Pichlmair. 
Gebhardt, A. *, Laudenbach, B.T. *, and Pichlmair, A. (2017). Discrimination of Self and 
Non-Self Ribonucleic Acids. J. Interf. Cytokine Res. 37, 184–197. *these authors contributed equally 
Reprinted with permission from JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, Volume 
37, Issue 5, May 2017, jir.2016.0092, published by Mary Ann Liebert, Inc., New Rochelle, NY. 
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1.2.2 Viral strategies to inhibit host gene expression and hijack host mRNA export factors 
All DNA and RNA viruses are prone to the IFN-induced cellular responses. Therefore, viruses 
established strategies to escape the cellular innate immune responses by masking their PAMPs (see 
chapter 1.2.1) and additionally they acquired the ability to interfere with almost all steps in gene 
expression in order to globally suppress host protein expression known as “host shutoff”. This 
includes inhibition of cellular events like transcription, mRNA processing, mRNA export from 
the nucleus, regulation of mRNA stability as well as multiple steps in translation. Through this 
mechanism, viruses not only dampen antiviral responses but also transfer cellular resources 
towards viral gene expression. In addition, nuclear replicating viruses including almost all DNA 
viruses (except poxviruses, asfarviruses and phycoviruses) and a few RNA viruses (bornaviruses, 
orthomycoviruses and retroviruses) have to compete with host mRNA for effective export of their 
viral mRNAs to successfully replicate and assemble in the host. In this section, I will focus on the 
viral manipulation of the host cell through two key viruses since they were predominantly used in 
the thesis research: Influenza A virus (Orthomyxoviridae) and Vesicular stomatitis virus 
(Rabhdoviridae). 
1.2.2.1 Influenza A virus  
Influenza A virus is a nuclear replicating, negative-orientated, single-stranded (ss) RNA virus 
belonging to the Orthomyxoviridae family. The influenza genome is segmented into eight fragments 
encoding for 12-14 structural and nonstructural proteins depending on the strain. IAV is a rapidly 
mutating virus resulting in the existence of a large number of different strains with varying 
non-essential functions, mostly involved in the modulation of virus-host interactions. However, 
a global block of host protein expression was generally observed in IAV infected cells. In this 
regard, three main mechanisms of host shutoff by IAV infection have been described: inhibition 
of cellular mRNA processing and nuclear export, degradation of host RNA polymerase II and 
wide-ranging degradation of host mRNA 256,257.  
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Figure 10: Mechanisms of cellular manipulation by influenza A virus. 
Influenza A virus (IAV) NS1 binds and inhibits factors involved in mRNA processing and export (top box). The functions of the 
viral RNA-dependent RNA polymerase (RdRp) leads to alteration of host gene expression by the combination of cap-snatching 
and cellular RNA polymerase II degradation (middle box). Through the nuclease activity of PA-X and its selectivity for polymerase 
II transcripts, cellular RNA is degraded committing to cellular host shutoff (bottom box). Cap, N7-methylguaosine; CBC, 
cap-binding complex; RNA Pol II, RNA polymerase II; TREX-1, transcription-export complex 1.Schematic and figure legend 
were adapted from references 221,258. 
NS1 mediated inhibition of polyadenylation and host mRNA export  
The non-structural protein 1 (NS1) is composed of a N-terminal RNA-binding domain and a 
C-terminal effector domain by which NS1 exhibits its function in several processes to inhibit type 
I IFN responses 259,260. The inhibition of innate immune responses by NS1 was underlined by the 
usage of IAV with a deleted NS1 protein (IAV-ΔNS1) 261,262. This virus replicates to a greater 
extent in IFN-α/β deficient cells (Vero cells) than in type I IFN competent cells (MCDK cells), 
in which virus infection results in elevated levels of IFN and IFN-stimulated genes. Additionally, 
in contrast to IAV wild-type, IAV-ΔNS1 is not lethal for mice as the innate immune system is not 
inhibited by viral NS1 protein. Therefore, the crucial role of NS1 is to counteract and 
down-regulate the host innate immune responses. In that manner, NS1 blocks nuclear processing 
of RNA polymerase II transcripts by forming a complex with CPSF30. CPSF30 is an important 
component of the cellular 3`end processing machinery, which is known as the cellular and 
polyadenylation specificity factor (CPSF) complex (Figure 10) 263. The CPSF complex cuts 
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pre-mRNA downstream of the polyadenylation signal and recruits poly(A) polymerase to 
polyadenylate the 3`end of the RNA. By binding CPSF30, NS1 prevents polyadenylation and 
consequently inhibits nuclear export of these incompletely processed mRNAs 264. In addition, NS1 
effector domain associates with the nuclear poly(A) binding protein (PABPN) and inhibits its 
function in synthesis of long poly(A) tails driven by poly(A) polymerase (Figure 10). The 
combination of blocking the CPSF complex activity and the synthesis of long poly(A) tails results 
in the accumulation of short poly(A) tailed mRNA that are less efficiently transported to the 
cytoplasm 264. A more direct effect on inhibiting mRNA export was shown by the interaction of 
NS1 with proteins such as NXF1-NXT1, RAE1 and E1B-AP5, proteins that all bind to cellular 
mRNA and nucleoporins to guide mRNAs through the nuclear pore (Figure 10) 265,266. 
Interestingly, the inhibition of mRNA export by NS1 could be reversed by the overexpression of 
NXF1. Additionally, it was shown that NS1 weakly binds Nup98 and initiates its degradation to 
further achieve a block in mRNA export from the nucleus. Surprisingly, not all IAV strains have 
the ability to carry out NS1-mediated host shutoff. Avian and swine IAV strains as well as the 
mouse-adapted laboratory strain A/PuertoRico/8/1934 (PR8) and the human pandemic 2009 
H1N1 strain carry NS1 proteins that do not inhibit mRNA 3`end processing 267–271. Several studies 
indicated that specific amino acids in NS1 are required for CPSF30 binding and that these residues 
vary between CPSF30-inhibiting and non-inhibiting strains. By mutating these residues in the 
non-inhibiting strains (avian and swine origin) to the NS1-consensus sequence, these strains 
showed an increased pathogenicity.  
Surprisingly, although NS1 has such a strong inhibitory effect on host mRNA export, a solid 
poly(A) signal can still be identified in the nucleus of IAV infected or NS1 transfected cells. This 
indicates that subsets of mRNAs may have the ability to bypass NS1-mediated mRNA processing 
inhibition. Indeed, the Stern-Ginossar group has recently shown that a subset of genes 
contributing to oxidative phosphorylation can escape degradation and are constantly expressed 
during general IAV host shutoff 257. Since oxidative phosphorylation is a cellular housekeeping 
function to generate biological usable energy and viruses are unable to produce their own energy, 
the authors hypothesized that bypassing these genes is one way to maintain or even increase energy 
production during host shutoff. 
In contrast to cellular mRNAs, viral mRNAs are not affected by the general shutoff mediated by 
NS1 since the polyadenylation of these transcripts is carried out by the viral RNA-dependent RNA 
polymerase (RdRp) by shuttering on a polyuridine stretch of the viral genome 257,272. Additionally, 
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some studies indicated that at least a few viral transcripts are exported in an NXF1-independent 
manner, thus, escaping the virus induced shut off mechanisms. 
RdRp mediated degradation of host RNA polymerase II  
The viral RdRp consists of the viral PB1, PB2 and PA subunits and associates with the cellular 
RNA polymerase II on actively transcribed genes including protein-coding mRNAs and snRNAs. 
The interaction occurs during the initiation of transcription and is dependent on serine 5 
phosphorylation of the CTD. In this state, the RNA polymerase II recruits factors to synthesize 
the 5`cap structure on nascent mRNA transcripts. Following the interaction of RdRp with this 
state of actively transcribed RNA, viral RdRp cleaves nascent transcripts close to the 5`end and 
uses this 5`capped RNA as primer for viral mRNA synthesis. This process, known as 
“cap-snatching”, leaves uncapped cellular RNA fragments for degradation (Figure 10). In addition, 
this process leads to ubiquitination of the large subunit of the RNA polymerase II and subsequently 
to its degradation by the proteasome. The combination of cap-snatching and RNA polymerase II 
degradation is an effective mechanism to alter host gene expression. However, by degrading RNA 
polymerase II the viral transcriptional activity also decreases since it is dependent on the 
interaction with RNA Pol II and cap-snatching. Nevertheless, the degradation of RNA 
polymerase II may support to shift from viral transcription to replication by favoring viral genomic 
synthesis instead of viral mRNA transcription. 
PA-X mediated RNA degradation  
Until now, it was commonly accepted that RNA degradation was an effect of cap-snatching by the 
RdRp. However, more recently evidence occurred that the viral protein PA-X is actively required 
for host shutoff (Figure 10). PA-X is the product of a +1 ribosomal frameshift after amino acid 
191 in PA protein ending in a short C-terminal domain (called X-ORF), which is responsible for 
host shutoff 273,274. The common N-terminal domain of PA and PA-X encodes a RNA endonuclease 
domain 274–276. X-ORF domain varies from 41 to 61 amino acids in different IAV strains, whereby 
only the first 15 amino acid are needed for host shutoff but the extended 61 amino acid versions 
have revealed stronger activity 277,278. RdRp subunit PA and its ssRNA cleaving potential may only 
be needed to cut pre-mRNA during cap-snatching, whereas, the endonuclease activity of PA-X 
with less specificity might be committed to host shutoff 277. A common feature of PA and PA-X 
endonuclease activity is that both proteins preferentially cleave RNA polymerase II transcripts and 
spare transcripts arising from viral RdRp transcription and other cellular RNA polymerases 277.  
Interestingly, IAV infections with decreased PA-X levels induced by mutating the 
frameshift-promoting sequence resulted in elevated immune responses in mice leading to a higher 
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pathogenicity due to increased lung immunopathology 274,279–281. Cells infected with the PA-X 
mutant IAV virus showed similar levels of viral mRNAs and vRNAs compared to IAV wild-type 
infection. However, viral proteins were less expressed indicating that PA-X reduces the pool of 
cellular mRNAs that access the translational machinery and thereby viral transcripts do not have 
to compete for translation with host mRNAs 282.  
Since PA-X production by ribosomal frameshift transcription is conserved among the various IAV 
strains 283, it indicates that PA-X triggered RNA degradation might be a general IAV mechanism 
for host shutoff and additional strain-dependent adaptions were added through evolution to 
compete with increased host complexity. 
1.2.2.2 Vesicular stomatitis virus 
Vesicular stomatitis virus (VSV) is a ssRNA virus with a negative-oriented linear genome 
belonging to the Rhabdoviridae family. In contrast to IAV, VSV replicates in the cytoplasm and 
therefore has no need to hijack the cellular mRNA export machinery. However, host mRNA 
export is rapidly repressed by the nuclear localizing viral matrix (M) protein to primarily dampen 
cellular innate immune responses 258,266. In addition, by blocking cellular mRNA export VSV 
decreases the competition with cellular mRNAs for the use of the translational machinery. 
Nuclear VSV M protein interacts with the RNA binding protein RAE1, which is in a complex with 
the nucleoporin Nup98 (Figure 11) 284,285. This interaction leads to the nuclear retention of 
mRNAs and snRNAs. Using crystallographic and biochemical studies, Quan et al. revealed the 
molecular mechanism of M-RAE1-Nup98 binding and inhibition of cellular mRNA export 286. 
Viral M proteins mimics the phosphate backbone by which it hijacks the nucleic acid binding site 
of RAE1 and sabotages cellular mRNA export.  
 
Figure 11: VSV disruption of cellular mRNA export. 
Vesicular stomatitis virus (VSV) matrix (M) protein interacts with RAE1 and Nup98 and thereby blocks cellular mRNA export to 
the cytoplasm. CBC, cap-binding complex; Cap, N7-methylguaosine; TREX-1, transcription-export complex 1. Schematic and 
figure legend were adapted from reference 258. 
The most prominent feature of protein M mimicking the phosphate backbone is the methionine 
on position 51 (M51) with its upstream and downstream acidic residues. Using VSV with a 
mutation in M51 to alanine (M51A) did not block mRNA export and immune responses were 
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mounted upon virus infection 287. Interestingly, M-mediated mRNA export block can be reverted 
by IFN since IFN stimulation increases the levels of RAE1 and Nup98/96 285,288,289. It has also been 
shown that M-RAE1-Nup98 interaction inhibits transcription 290. However, several studies 
demonstrated that high levels of bulk poly(A) RNA are retained in the nucleus in the presence of 
VSV-M expression indicating that the cellular transcripts are properly polyadenylated and that 
VSV-M uses post-transcriptional mechanisms to block host gene expression 258. Since 
nucleoplasmic Nup98 has been indicated to regulate a subset of RNA polymerase II genes 291,292, 
it might be possible that the VSV M protein thereby specifically inhibits transcription of certain 
Nup98-dependent genes. RAE1 and Nup98 were shown to regulate spindle assembly during 
mitosis 293,294, which has a high impact in cancer cells due to their high mitotic index. The 
interaction of VSV M and RAE1-Nup98 complex inhibits mitotic progression and leads to cell 
death 295, which likely contributes to VSV`s oncological potential. The potential of VSV to 
preferentially infect cancer cells and inhibiting mitotic progression leading to cell death is used in 
the development of new cancer therapeutics 296. 
In summary, inhibition of cellular mRNA export by the interaction of VSV-M protein with 
RAE1-Nup98 helps the virus to exclusively access the translational machinery and avoid the 
competition with host mRNAs for translation. In addition, the block of mRNA export inhibits the 
expression of immune regulated genes.  
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1.3 Importance of viral RNA-binding proteins for viral 
replication 
Single-stranded RNA viruses are classified according to their positively (+) or negatively (-) 
encoded genome. Depending on the orientation, the viral genetic information is translated 
directly into functional proteins ((+) RNA genome) or it is transcribed into positively orientated 
RNA ((-) RNA genome) by the viral RdRp. Translation of viral proteins produce structural and 
non-structural proteins that are involved in the architecture of the viral particle or participate in 
the transcription and replication of the viral genome, respectively. Assembly of functional viral 
particles includes genome replication. For both, (+) and (-) ssRNA viruses, the viral RNA 
polymerase generates a complementary RNA (cRNA) intermediate as template for the replication 
of the RNA genome. In this process, viral non-structural proteins with RNA-binding ability are 
involved and crucial for successful execution of the replication process. In the following section, 
I will highlight the importance of two viral RNA-binding proteins, namely the NP protein of 
influenza A virus ((-) RNA virus) and the non-structural 5A (NS5A) protein of hepatitis C virus 
(HCV; (+) RNA virus), in virus replication.  
1.3.1 Nucleoprotein of influenza A virus 
Each segment of the negative-orientated influenza virus genome is coated by multiple copies of 
NP that form together with one RdRp complex the vRNP, the minimal functional unit for viral 
transcription and replication (Figure 12, box) 297,298. Comparing NPs of different 
negative-stranded RNA viruses has revealed two shared features of NP: a positively charged 
RNA-binding groove and broad contacts between neighboring NP molecules 298. Influenza A virus 
NP was shown to bind RNA with high affinity in a sequence-independent manner potentially 
through the positively charged cleft between the head and the body domain 299,300. In addition, 
crystal structures of NP revealed a tail loop structure which enables NP molecules to form 
oligomeric structures 299,300. These oligomeric structures were shown to be required for RNP 
activity 301. Studies using artificial mini vRNA of 81 nt length demonstrated that NP can melt 
secondary RNA structures proposing that NP functions in genome replication by supporting 
transcript elongation 300. Indeed, for full-length genome replication NP is absolutely required, 
whereas, the viral RdRp consisting of PB1, PB2 and PA was shown in vitro and in vivo to be 
adequate to replicate short RNA templates in the absence of NP 302–307. Moreover, NP stimulates 
polymerase activity 305,308. This highlights the important of NP for successful and complete 
replication of the viral genomes. The current model of viral RNA transcription and replication 
(stabilization model) proposes that the synthesis of cRNA and mRNA from virion-derived RNPs 
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is stochastic 309. However, for stabilization and replication of cRNA the active expression of 
polymerase and NP molecules is important. This was supported by the finding that the 
RNA-binding activity of NP is needed to stabilize cRNA and that both, RNA-binding and NP 
oligomerization, promote replication 309. It was suggested by the model that newly synthesized 
RdRp and NP molecules are required to stabilize and protect cRNA from cellular degradation. 
Newly synthesized NP molecules were shown to be kept in a monomeric form before being 
recruited to nascent cRNAs by the interaction with RdRp, which is bound first to emerging 5´ends 
of cRNAs 301,307,310,311. 
 
Figure 12: Life cycle of influenza A virus. 
The life cycle of Influenza A virus includes the following steps: (1) Virion binding to cell surface receptors containing sialic acid, 
(2) Endocytosis of the virion and release of the vRNP to the cytoplasm, (3) Nuclear import of vRNP, (4) Cap-snatching and 
transcription of viral segments into mRNA, (5) Export of viral mRNAs, (6) Translation and nuclear re-import of viral proteins, 
(7) Replication of vRNPs by the viral RNA polymerase producing an intermediate complementary RNA (cRNA), (8) Export of 
vRNP, (9) vRNP transport and virion assembly and (10) Budding of the viral particles. The box schematically indicates the 
architecture of a vRNP containing RdRp (PB1, PB2 and PA), NP proteins and the viral RNA (vRNA). Cap, N7-methylguanosine; 
RdRp, RNA-dependent RNA polymerase; vRNP, viral ribonucleoprotein particles. Schematic and figure legend were adapted 
from reference 297. 
Subsequently, additional monomeric NP molecules are bound through tail loop interactions 
forming oligomeric structures. Phosphorylation and the interaction with cellular proteins like 
importin α5 were shown to be required to keep NP as monomer before it is assembled into 
oligomeric structures incorporating viral RNA into the coiled vRNP structures 312–315.Altogether, 
RNA-associated NP is required during viral genome replication for full functionality of viral RdRp 
during elongation of the cRNA (Figure 12). The high affinity to RNA and the regulation through 
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post-translational modifications like phosphorylation of NP molecules play an important role in 
the function of NP.  
1.3.2 Non-structural 5A protein of hepatitis C virus 
The positively orientated HCV genome is translated at the rough endoplasmic reticulum (ER) in 
a cap-independent manner by the existence of an internal ribosomal entry site (IRES) in the 
5´non-coding region (5´NCR) of the viral RNA (Figure 13) 316. This yields a polyprotein that is 
subsequently cleaved into ten structural and non-structural (C, E1, E2, p7, NS2, NS3, NS4A, 
NS4B, NS5A and NS5B) proteins by cellular (e.g. signal peptidase) and viral proteases (NS2, 
NS3-4A). After cleavage from the polyprotein, the non-structural proteins function in several 
steps of the viral life cycle (Figure 13).  
One of this process is the RNA replication of HCV genomes, which occurs in membranous derived 
structures from the ER known as “membranous web” that contain cellular and non-structural viral 
proteins, HCV RNA, ER membranes and lipid droplets 317,318. The synthesis of negative-strand 
RNA is thought to be initiated through the recognition of a sequence motif in the 3`UTR of HCV 
RNA by the RdRp NS5B (Figure 13) 319–321. Template specificity and replication activity of NS5B 
are dependent on the presence of NS2 and NS3 as well as the multifunctional NS5A protein 319. 
NS5A was shown to be unconditionally required for viral replication and additionally involved in 
viral particle assembly (specific function is unknown) 322–326. NS5A is a proline-rich 
phosphoprotein consisting of an N-terminal amphipathic α-helix anchoring NS5A to the ER lumen 
and a cytoplasmic portion organized into three domains (domain I, II and III) separated by 
low-complexity regions (LCS) I and II. Domain I is highly conserved among HCV genotypes and 
contains a zinc-binding motif required for dimerization of the N-terminal ends 327. Mutations in 
the four cysteines of the zinc-binding domain showed that this domain is critical for viral 
replication and NS5A dimerization 328. Through dimerization, a basic groove at the dimeric 
interface is exposed by which NS5A associates with newly synthesized viral RNA during 
replication 328–332. In addition, it was demonstrated that NS5A preferentially binds the 
polypyrimidine regions of the 3`UTR, but it can also associate with uridylate- and guanylate-rich 
(U/G) stretches in the IRES of the 5´UTR 329,330. The latter association was suggested to influence 
HCV translation, while binding to the conserved polypyrimidine stretch of the 3´UTR is essential 
for replication. Additionally, it was suggested that through binding of the viral RNA, NS5A 
protects the RNA from degradation by cellular RNAses as well as from recognition by the innate 
immune system316. This hypothesis was supported by the fact that only a small proportion of the 
expressed NS5A is required for RNA replication, suggesting that the excess of protein could 
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participate in shielding the viral RNA from sensing by the host 333,334. In this regard, a recent study 
revealed that formation of the “membranous web” limits the access of PRRs to viral replication 
sites and protects from innate immune sensing 335. NS5A domains II and III are less well conserved 
among HCV genotypes and are highly disordered in solution 327. This flexibility was indicated to 
be important to interact with a variety of cellular proteins that are required for NS5A function 
and virus persistence. Domain III was shown to be non-relevant for RNA replication, however, 
required for successful assembly of viral particles 323,336,337. Importantly, regions within domain I 
and II interact with NS5B and stimulates viral RNA polymerase activity in-vitro 338,339.  
 
Figure 13: Life cycle of hepatitis C virus. 
The top box shows the hepatitis C virus (HCV) internal ribosome entry site (IRES) mediated translation and polyprotein 
processing. The HCV genome (9.6 kDa positive-stranded RNA) organization is depicted. Secondary structure is shown in a 
simplified manner representing the 5′- and 3′-non-coding regions (NCRs) and the core gene. IRES-mediated translation results in 
a polyprotein precursor that is co- and post-translationally processed into the mature structural and non-structural proteins (C, 
E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B). The bottom depicts a schematic of the viral life cycle with the following 
steps: (1) Viral entry, (2) Cytoplasmic release and uncoating, (3) IRES-mediated translation and polyprotein processing, (4) RNA 
replication, (5) Virion maturation and release and (6) Viral particle packaging and assembly. The topology of HCV structural and 
non-structural proteins at the endoplasmic reticulum is indicated schematically. Schematic and figure legend were adapted from 
reference 316. 
INTRODUCTION 
47 | P a g e  
 
Intracellularly, NS5A is present as a basally phosphorylated (56 kDa) and hyperphosphorylated 
(58 kDa) form 316. Mass spectrometry based studies have revealed that the LCS I region is 
extensively phosphorylated during HCV replication 340–342. In addition, phosphorylation sites 
within domain I, II and LCS II have been detected. Several studies showed that serine residues 
within LCS I are important for viral replication. However, these phosphorylation marks are HCV 
genotype dependent. Serine 225 phosphorylation within LCS I was demonstrated to be important 
for correct localization of viral and cellular proteins involved in viral replication. Consequently, 
mutations in S225 resulted in reduction in viral replication 343. In sum, NS5A is a highly regulated 
protein and a plethora of studies have revealed it’s important for successful HCV replication. In 
particular, phosphorylation within LCS I was demonstrated to be dynamically regulated and 
fundamental for genome replication. 
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1.4 Objective of the thesis 
In eukaryotes, the transfer of genetic information from DNA to RNA intermediates and finally to 
functional proteins is fundamental for every single cell. The separation of the cell into the nucleus and the 
cytoplasm is one important barrier to separate transcription from translation and to precisely regulate and 
control gene expression. One essential step in the transmission from DNA to a functional protein is the 
active transport of mRNA from the nucleus to the cytoplasm. The central player, which is co-
transcriptionally bound to the RNA cap structure and triggers processing and export of mRNA, is the 
canonical CBC. This complex consisting of NCBP2 and its adapter protein NCBP1 was already identified 
almost 30 years ago by two independent studies of Mutsuhito Ohno and Elisa Izaurralde 125,344.  
During my thesis, I challenged the long-standing dogma that the canonical CBC is critically required for 
mRNA processing and export. This interest was sparked by very elegant inhibition experiments that had 
shown that loss of NCBP2 impairs snRNA export but not mRNA export 94. More recently, siRNA-based 
screens supported this data and draw my awareness to study whether additional components are required 
for mRNA processing 345–347. I first sought to investigate the eukaryotic repertoire of cap-binding proteins 
to identify potential candidates that could compensate for the loss of NCBP2. The aim of my thesis was 
to characterize the role of the identified candidate/s in mRNA processing and export. I managed to 
identify and functionally characterize an alternative CBC that is assembled by NCBP1 and -3 and functions 
in a redundant manner with the canonical CBC under steady-state conditions. I could show that the 
alternative CBC is important during conditions of cellular stress, which I demonstrated in virus infection 
experiments using loss of function assays. 
During viral infections, mRNA processing is regulated by the function of viral proteins that are themselves 
target of post-translational regulatory mechanisms. In this manner, serine, threonine or tyrosine 
phosphorylation plays a fundamental role in regulating the function of proteins. For viral proteins, 
regulation of phosphorylation-sites may be required for proper viral replication. In collaboration with the 
lab of Marc Harris (University of Leeds, United Kingdom), we investigated the effect of post-translational 
modifications of the viral protein NS5A on viral replication. In this manner, I analysed the influence of 
NS5A S225 phosphorylation on the interaction with cellular proteins.  
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2 Results 
2.1 Publication 1: mRNA export through an additional cap-binding complex consisting 
of NCBP1 and NCBP3 
Gebhardt, A.*, Habjan, M.*, Benda, C., Meiler, A., Haas, D.A., Hein, M.Y., Mann, A., Mann, 
M., Habermann, B., and Pichlmair, A. (2015). mRNA export through an additional cap-binding 
complex consisting of NCBP1 and NCBP3. Nat. Commun. 6, 8192. *these authors contributed equally 
 
The manuscript “mRNA export through an additional cap-binding complex consisting of NCBP1 
and NCBP3” describes the first identification and characterization of the cap-binding protein 
NCBP3. Mass spectrometry based identification of the human and mouse cap-binding protein 
repertoire revealed the existence of a till then poorly characterized protein encoded by the open 
reading frame 85 of chromosome 17 (C17orf85). Biochemical analysis confirmed the direct 
binding of C17orf85 to the mRNA cap structure in an N7-methylguanosine-dependent manner. 
We renamed C17orf85 to nuclear cap-binding protein 3 (NCBP3). Additional experiments 
demonstrated the participation of NCBP3 together with NCBP1 in an alternative cap-binding 
complex. Depletion experiments showed that for appropriate cell viability and distribution of 
cellular polyadenylated RNA the function of either NCBP2 or NCBP3 is required demonstrating 
that the alternative (NCBP1/3) and the canonical (NCBP1/2) cap-binding complex execute 
redundant function under physiological conditions.  
The main text including material and methods and supplementary information are displayed in 
the following. Supplementary tables can be downloaded from the website of Nature Communications 
(https://www.nature.com/articles/ncomms9192). 
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2.2 Publication 2: The alternative cap-binding complex is required for antiviral 
response in vivo 
Gebhardt, A., Schnepf, D., Moser, M., Meiler, A., Michaudel, C., Mackowiak, C., Sedda, D., 
Stukalov, A., Reinert, L., Paludan, S.R., Ryffel, B., Stäheli, P., and Pichlmair, A. (2018). The 
alternative cap-binding complex is required for antiviral response in vivo. (prepared for 
submission) 
 
The manuscript “The alternative cap-binding complex is required for antiviral response in vivo.” 
investigates the requirement of the alternative CBC during viral infections. In vitro experiments 
showed that the alternative CBC subunit NCBP3 is required to regulate appropriate expression 
of innate immune response genes and is involved in restriction of viral infections. I established a 
NCBP3 knockout mouse model and could show that NCBP3 is required to pertain influenza A 
virus mediated pathology in vivo. Combining in vitro and in vivo data highlighted that the alternative 
CBC is fundamental to combat viral infections. NCBP3 appears to be involved in the precise 
regulation of antiviral gene expression.  
The manuscript prepared for submission is presented below and includes results, discussion, 
material and methods and supplementary information. Supplementary table can be provided on 
request.  
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2.3 Publication 3: Phosphorylation of serine 225 in hepatitis C virus NS5A regulates 
protein-protein interactions 
Goonawardane, N., Gebhardt, A., Bartlett, C., Pichlmair, A., and Harris, M. (2017). 
Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions. J. 
Virol. JVI.00805-17. 
 
The manuscript “Phosphorylation of serine 225 in hepatitis C virus NS5A regulates 
protein-protein interactions” describes the molecular mechanism of NS5A serine 225 (S225) in 
regulating hepatitis C virus (JFH-1, genotype 2a) genome replication. Mass spectrometry based 
analysis revealed that the phosphoablatant mutant (S225A) lost the ability to interact with a 
number of cellular proteins including the nucleosome assembly protein 1-like protein 1 
(NAP1L1), bridging integrator 1 (Bin1, also known as amphiphysin II), and vesicle-associated 
membrane protein-associated protein A (VAP-A). Previous studies demonstrated that infection 
with NS5A phosphoablatant mutant (S225A) HCV results in reduced virus replication and 
perinuclear distribution of NS5A. Similar, knockdown of the three cellular NS5A interacting 
proteins, namely NAP1L1, Bin1 and VAP-A, impaired viral genome replication and led to 
perinuclear distribution of NS5A demonstrating the importance of NS5A S225 phosphorylation 
in regulating cellular interactions which are required for successful viral genome replication.  
The main text including material and methods is represented in the following. Supplementary 
tables can be downloaded from Journal of Virology`s publishing website 
(http://jvi.asm.org/content/early/2017/06/08/JVI.00805-17). 
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3 Concluding remarks and outlook 
Using mass spectrometry and biochemical methods, I identified the largely uncharacterized 
protein C17orf85 (now named NCBP3) as a cap-binding protein that, together with NCBP1, 
forms the alternative CBC enabling export of mRNA from the nucleus. Under physiological 
conditions, the alternative and canonical CBC function in a redundant manner. Through the 
identification of the alternative CBC, I identified a critical additional part for mRNA processing 
and showed that mRNA export is more complex than previously thought. Supportively for that 
notion, other recent studies have also suggested previously unappreciated complexity in the 
process of mRNA export. It became evident that besides the constitutive export of bulk mRNA, 
export of transcripts can be highly selective, allowing priority export for some mRNAs over 
others 221. The identification of the alternative CBC raises many questions and facilitates further 
regulatory possibilities related to mRNA export and quality control. Current questions vary from 
the molecular composition and cooperation of the CBC subunits and their binding to the cap 
structure as well as the mechanism behind the engagement of other macromolecule complexes 
like the EJC or TREX complexes to the functional requirement of two redundant CBCs.  
Investigating the molecular composition and cooperation of the CBC subunits is of fundamental 
importance to understand the synergies and discrepancies in binding of the subunits to each other 
and their interaction with the cap structure. The interaction between NCBP1 and NCBP2 as well 
as between NCBP2 and the cap structure has been studied using structural approaches 348,349. 
Comparative modelling for NCBP3 using HHpred revealed a structural model based on the RRM 
of poly(A)-specific ribonuclease (PARN). The similarity to the RRM of PARN suggests a similar 
cap-binding mode for NCBP3 engaging the cap structure by stacking the cap on a single aromatic 
amino acid (tryptophan). In contrast, NCBP2 as well as the cytoplasmic cap-binding protein eIF4E 
sandwich the RNA cap structure between two aromatic amino acids (Figure 14). For NCBP3, the 
structure prediction model allowed to identify critical residues and suggested similar binding as 
seen for PARN. However, it is likely that other aromatic amino acids contribute to the cap-binding 
of NCBP3. More detailed structural analysis using x-ray crystallography or cryo-electron 
microscopy combined with mutational and functional experiments may be necessary to identify 
the exact binding mode of capped RNA to NCBP3. 
An atomic structure of the NCBP1/3 complex in comparison with the crystal structure of the 
NCBP1/2 complex could help to understand whether the binding of NCBP3 is mutually exclusive 
or whether a trimeric complex of NCBP1/2/3 exists. Moreover, structural information could 
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support the understanding of RNA selectivity by the two CBCs. Further investigation of the 
influence of NCBP2 on the binding between NCBP1 and -3 and vice versa, the influence of NCBP3 
on NCBP1/2 interaction, would be needed to understand the synergies and discords of the two 
complexes in eukaryotes. 
 
Figure 14: Comparison of cap-binding pockets for PARN, NCBP2 and eIF4E. 
Amino acid residues of poly(A)-specific ribonuclease (PARN), nuclear cap-binding protein 2 (NCBP2) and eukaryotic initiation 
factor 4E (eIF4E) involved in binding to the m7G cap structure. Amino acids are shown in ball-and-stick mode. Red, oxygen; 
green, phosphor; blue, nitrogen; yellow, carbon. Schematic and figure legend were adapted from reference 350. 
The binding of the CBCs is required to recruit cellular components that are fundamental for RNA 
processing. However, it is still unclear how the two CBCs select the binding of the right RNA 
processing factors for the given type of RNA. We showed that NCBP2 and NCBP3 associate with 
EJC and TREX factors to different extents, preferentially binding to NCBP3. However, PHAX, 
which is the export adaptor for snRNAs export, only associated with NCBP2. EJC, TREX and 
PHAX are recruited to mRNA via NCBP1, a common protein of the canonical and the alternative 
CBC. It is therefore likely that association of NCBP2 or NCBP3 to NCBP1 exposes or blocks 
binding sites on NCBP1 for RNA processing factors and thereby mediates selectivity in recruiting 
specific RNA processing factors. Compared to NCBP2, NCBP3 is a relatively large protein of 
~70 kDa with a disordered C-terminal domain. Through interaction with NCBP1 or other 
factors, the C-terminal domain may fold and engage mRNA processing factors like EJC and TREX 
subunits. The contribution of NCBP3`s C-terminal domain for the recruitment of mRNA 
processing factors could be addressed by combining structural analysis with functional and 
mutational biochemical experiments.  
Altogether, the molecular basis of the interplay between the subunits of the alternative and 
canonical CBC and their engagement of auxiliary mRNA processing factors will allow to better 
understand the apparent redundancy of the two CBCs. We questioned why the human organism 
encodes for two CBCs with apparently redundant function. Different reasons could be possible: 
PARN NCBP2 eIF4E 
CONCLUDING REMARKS ANS OUTLOOK 
 
135 | P a g e  
 
(1) The two CBCs may be separated in labour and ensure proper processing of all needed RNAs. 
Naturally, the alternative and canonical CBC handle different types of RNA (e.g. snRNA and 
mRNA), however, during loss of one complex the other can compensate for the loss establishing 
a form of fallback mechanism. (2) Two CBCs may be necessary under conditions demanding 
regulation of RNA processing, e.g. during conditions of environmental stress or developmental 
processes. (3) The two CBCs may be regulated in their activity, which opens the possibility to 
promote usage of one CBC over the other. 
In my second first author publication, investigating the relevance of the alternative CBC during 
virus infection, I could demonstrate that the alternative CBC is required to constrain viral 
infections. This supports the possibility that the two CBCs evolved to regulate RNA turnover 
during environmental stress conditions such as viral infections. Although I could show that the 
expression of a subset of ISGs is regulated by NCBP3, the exact mechanism how the alternative 
CBC is selected for export of this subset of mRNA is still unclear. In this scenario, a regulation of 
the CBCs by post-translational modifications could be likely. One commonly found modification 
is the phosphorylation of serine, threonine or tyrosine. Several phospho-sites were identified in 
NCBP1, -2 and -3 having the ability to be regulated by environmental stimuli 351–353,353–358. 
Interestingly, mass spectrometry based identification of phosphorylation changes (preliminary, 
unpublished data) revealed that defined residues in NCBP1 and NCBP3 change their 
phosphorylation state in response to stimulation with IFN. This supports the possibility that the 
alternative CBC is regulated upon environmental stimuli by post-translational modifications. To 
elucidate the underlying mechanism, further experiments involving mutational and functional 
experiments are required, which could demonstrate that gene expression is controlled on a yet 
unappreciated level.  
Respiratory infections with influenza A virus are a major cause of death worldwide 359–361. 
Therefore, it is of outstanding interest to understand how severity of disease and pathogenicity 
towards respiratory virus infections is regulated. Infection of Ncbp3 deficient mice with IAV 
caused severe lung pathology resulting in high morbidity highlighting the influence of Ncbp3 on 
the outcome of disease. The expression of antiviral programs needs proper regulation to 
immediate and timely express cytokines and antiviral proteins as well as to express negative 
regulators to prevent overshooting of the system 362–365. This regulation could be maintained by 
the function of Ncbp3 and thereby loss of Ncbp3 results in the dysregulation of cellular antiviral 
programs resulting in lung pathology and mortality. Further research is needed to understand the 
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exact mechanism how Ncbp3 influences the severity of disease, which could help to prevent 
and/or treat virus-associated respiratory diseases. 
Viruses evolved mechanisms to manipulate cellular mRNA processing and export machineries to 
either dampen innate immune responses and/or to hijack cellular resources for viral replication. 
IAV and VSV are highly potent in disrupting cellular mRNA processing pathways. Until now, the 
influence of the two viruses on mRNA export was only shown by interrupting functions of nuclear 
pore associated proteins. A direct influence of viral proteins on Ncbp3 to prevent expression of 
innate immune regulated genes may also be possible. However, this hypothesis needs further 
investigations by firstly investigating if viral proteins potentially can interact with Ncbp3 and if so, 
by secondly examining the underlying cellular mechanism of viral NCBP3 manipulation. 
HCV infection is a major cause of acute hepatitis and chronic liver disease affecting more than 170 
million people and being a widespread problem 366. Understanding the molecular basis of HCV 
infection and replication is of major importance to prevent disease and improve disease outcome. 
Basic research on HCV life cycle lead to the development of directly acting antiviral (DAA) drugs 
currently used for the treatments of HCV infection 367. NS5A is a highly phosphorylated protein 
and it will be challenging to descramble the unique function and the functional consequences of 
all NS5A phosphorylations. However, our finding that phosphorylation of serine 225 of HCV 
NS5A protein contributes to efficient HCV genome replication through the interaction with the 
cellular proteins NAPL1, Bin1 and VAP-A, shed light onto a very complex system and refined our 
understanding of the complexity of post-translational modifications for virus-host interaction. 
Since HCV genetics are highly variable and drug resistant strains are developing very rapidly 368, 
it is of great importance to break down the molecular basis for viral replication to establish new 
DAA agents. Recently, a class of NS5A targeting agents were developed and are very promising 
for the treatment of HCV infections 369. In this regard, the insights we gained investigating NS5A 
S225-dependent cellular interactions may be useful for the generation and selection of new 
antiviral drugs. 
In summary, the results presented in my thesis emphasize the importance to continuously reassess 
molecular mechanisms that are thought to be well established. Basic research still reveals yet 
undescribed cellular mechanisms, which are fundamental for our basic understanding of life, 
which can be used for the discovery of new and effective drugs that may be used for therapeutic 
purposes in the future. 
REFERENCES 
 
137 | P a g e  
 
References 
1. Kabachinski, G. & Schwartz, T. U. The nuclear pore complex – structure and function at a glance. 
J. Cell Sci. 128, (2015). 
2. Delaleau, M. & Borden, K. L. B. Multiple Export Mechanisms for mRNAs. Cells 4, 452–73 
(2015). 
3. Ohno, M., Fornerod, M. & Mattaj, I. W. Nucleocytoplasmic transport: the last 200 nanometers. 
Cell 92, 327–36 (1998). 
4. Kuersten, S., Ohno, M. & Mattaj, I. W. Nucleocytoplasmic transport: Ran, beta and beyond. 
Trends in Cell Biology 11, 497–503 (2001). 
5. Köhler, A. & Hurt, E. Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol. 
8, 761–73 (2007). 
6. Hopper, A. K. & Phizicky, E. M. tRNA transfers to the limelight. Genes Dev. 17, 162–180 (2003). 
7. Wolin, S. L. & Matera, A. G. The trials and travels of tRNA. Genes Dev. 13, 1–10 (1999). 
8. Melton, D. A., De Robertis, E. M. & Cortese, R. Order and intracellular location of the events 
involved in the maturation of a spliced tRNA. Nature 284, 143–148 (1980). 
9. De Robertis, E. M., Black, P. & Nishikura, K. Intranuclear location of the tRNA splicing enzymes. 
Cell 23, 89–93 (1981). 
10. Arts, G. J., Kuersten, S., Romby, P., Ehresmann, B. & Mattaj, I. W. The role of exportin-t in 
selective nuclear export of mature tRNAs. EMBO J. 17, 7430–41 (1998). 
11. Kutay, U. et al. Identification of a tRNA-specific nuclear export receptor. Mol. Cell 1, 359–69 
(1998). 
12. Lipowsky, G. et al. Coordination of tRNA nuclear export with processing of tRNA. RNA 5, 539–
49 (1999). 
13. Lund, E. & Dahlberg, J. E. Proofreading and aminoacylation of tRNAs before export from the 
nucleus. Science 282, 2082–5 (1998). 
14. Shaheen, H. H. & Hopper, A. K. Retrograde movement of tRNAs from the cytoplasm to the 
nucleus in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 102, 11290–11295 (2005). 
15. Takano, A., Endo, T. & Yoshihisa, T. tRNA Actively Shuttles Between the Nucleus and Cytosol 
in Yeast. Science (80-. ). 309, 140–142 (2005). 
16. Yoshihisa, T., Yunoki-Esaki, K., Ohshima, C., Tanaka, N. & Endo, T. Possibility of cytoplasmic 
pre-tRNA splicing: the yeast tRNA splicing endonuclease mainly localizes on the mitochondria. 
Mol. Biol. Cell 14, 3266–79 (2003). 
17. Murthi, A. et al. Regulation of tRNA Bidirectional Nuclear-Cytoplasmic Trafficking in 
Saccharomyces cerevisiae. Mol. Biol. Cell 21, 639–649 (2010). 
18. Whitney, M. L., Hurto, R. L., Shaheen, H. H. & Hopper, A. K. Rapid and reversible nuclear 
accumulation of cytoplasmic tRNA in response to nutrient availability. Mol. Biol. Cell 18, 2678–86 
(2007). 
19. Hurto, R. L., Tong, A. H. Y., Boone, C. & Hopper, A. K. Inorganic Phosphate Deprivation 
Causes tRNA Nuclear Accumulation via Retrograde Transport in Saccharomyces cerevisiae. 
Genetics 176, (2007). 
REFERENCES 
 
138 | P a g e  
 
20. Pierce, J. B., Eswara, M. B. K. & Mangroo, D. The ins and outs of nuclear re-export of 
retrogradely transported tRNAs in Saccharomyces cerevisiae. Nucleus 1, 224–230 (2010). 
21. Eswara, M. B. K., McGuire, A. T., Pierce, J. B. & Mangroo, D. Utp9p facilitates Msn5p-mediated 
nuclear reexport of retrograded tRNAs in Saccharomyces cerevisiae. Mol. Biol. Cell 20, 5007–25 
(2009). 
22. Kramer, E. B. & Hopper, A. K. Retrograde transfer RNA nuclear import provides a new level of 
tRNA quality control in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 110, 21042–7 
(2013). 
23. Hopper, A. K. Transfer RNA Post-Transcriptional Processing, Turnover, and Subcellular 
Dynamics in the Yeast Saccharomyces cerevisiae. Genetics 194, 43–67 (2013). 
24. Shaheen, H. H. et al. Retrograde nuclear accumulation of cytoplasmic tRNA in rat hepatoma cells 
in response to amino acid deprivation. Proc. Natl. Acad. Sci. 104, 8845–8850 (2007). 
25. Pierce, J. B. & Mangroo, D. Schizosaccharomyces pombe , unlike Saccharomyces cerevisiae , may not 
directly regulate nuclear-cytoplasmic transport of spliced tRNAs in response to nutrient 
availability. Biochem. Cell Biol. 89, 554–561 (2011). 
26. Chafe, S. C., Pierce, J. B., Eswara, M. B. K., McGuire, A. T. & Mangroo, D. Nutrient stress 
does not cause retrograde transport of cytoplasmic tRNA to the nucleus in evolutionarily diverse 
organisms. Mol. Biol. Cell 22, 1091–103 (2011). 
27. Johnstone, A. D., Mullen, R. T. & Mangroo, D. Plants, like mammals, but unlike Saccharomyces, 
do not regulate nuclear-cytoplasmic tRNA trafficking in response to nutrient stress. Plant Signal. 
Behav. 6, 1183–1188 (2011). 
28. Miyagawa, R., Mizuno, R., Watanabe, K. & Ijiri, K. Formation of tRNA granules in the nucleus 
of heat-induced human cells. Biochem. Biophys. Res. Commun. 418, 149–155 (2012). 
29. Arts, G.-J., Fornerod, M. & Mattaj,  lain W. Identification of a nuclear export receptor for tRNA. 
Curr. Biol. 8, 305–314 (1998). 
30. Calado, A., Treichel, N., Müller, E.-C., Otto, A. & Kutay, U. Exportin-5-mediated nuclear 
export of eukaryotic elongation factor 1A and tRNA. EMBO J. 21, 6216–24 (2002). 
31. Bohnsack, M. T. et al. Exp5 exports eEF1A via tRNA from nuclei and synergizes with other 
transport pathways to confine translation to the cytoplasm. EMBO J. 21, 6205–15 (2002). 
32. Hellmuth, K. et al. Yeast Los1p has properties of an exportin-like nucleocytoplasmic transport 
factor for tRNA. Mol. Cell. Biol. 18, 6374–86 (1998). 
33. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–97 
(2004). 
34. Kim, V. N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 
376–385 (2005). 
35. Valencia-Sanchez, M. A., Liu, J., Hannon, G. J. & Parker, R. Control of translation and mRNA 
degradation by miRNAs and siRNAs. Genes Dev. 20, 515–524 (2006). 
36. Leung, A. K. L. The Whereabouts of microRNA Actions: Cytoplasm and Beyond. Trends Cell Biol. 
25, 601–610 (2015). 
37. Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051–60 
(2004). 
38. CAI, X., Hagedorn, C. H. & Cullen, B. R. Human microRNAs are processed from capped, 
REFERENCES 
 
139 | P a g e  
 
polyadenylated transcripts that can also function as mRNAs. RNA 10, 1957–1966 (2004). 
39. Borchert, G. M., Lanier, W. & Davidson, B. L. RNA polymerase III transcribes human 
microRNAs. Nat. Struct. Mol. Biol. 13, 1097–1101 (2006). 
40. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419 
(2003). 
41. Han, J. et al. Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 
Complex. Cell 125, 887–901 (2006). 
42. Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F. & Hannon, G. J. Processing of 
primary microRNAs by the Microprocessor complex. Nature 432, 231–235 (2004). 
43. Gregory, R. I. et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 
235–240 (2004). 
44. Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear Export of MicroRNA 
Precursors. Science (80-. ). 303, 95–98 (2004). 
45. Bohnsack, M. T., Czaplinski, K. & Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-
binding protein that mediates nuclear export of pre-miRNAs. RNA 10, 185–91 (2004). 
46. Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear export of pre-
microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–6 (2003). 
47. Okada, C. et al. A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery. 
Science (80-. ). 326, 1275–1279 (2009). 
48. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease 
in the initiation step of RNA interference. Nature 409, 363–366 (2001). 
49. Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199–
208 (2003). 
50. Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. 
Cell 115, 209–16 (2003). 
51. Ha, M. & Kim, V. N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509–524 
(2014). 
52. Berezikov, E., Chung, W.-J., Willis, J., Cuppen, E. & Lai, E. C. Mammalian Mirtron Genes. 
Mol. Cell 28, 328–336 (2007). 
53. Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M. & Lai, E. C. The Mirtron Pathway Generates 
microRNA-Class Regulatory RNAs in Drosophila. Cell 130, 89–100 (2007). 
54. Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P. & Blelloch, R. Mouse ES cells express 
endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small 
RNAs. Genes Dev. 22, 2773–2785 (2008). 
55. Chong, M. M. W. et al. Canonical and alternate functions of the microRNA biogenesis machinery. 
Genes Dev. 24, 1951–1960 (2010). 
56. Xie, M. et al. Mammalian 5’-capped microRNA precursors that generate a single microRNA. Cell 
155, 1568–80 (2013). 
57. Cheloufi, S., Dos Santos, C. O., Chong, M. M. W. & Hannon, G. J. A dicer-independent miRNA 
biogenesis pathway that requires Ago catalysis. Nature 465, 584–589 (2010). 
58. Cifuentes, D. et al. A Novel miRNA Processing Pathway Independent of Dicer Requires 
Argonaute2 Catalytic Activity. Science (80-. ). 328, 1694–1698 (2010). 
REFERENCES 
 
140 | P a g e  
 
59. Yang, J.-S. et al. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-
mediated microRNA biogenesis. Proc. Natl. Acad. Sci. 107, 15163–15168 (2010). 
60. Yoda, M. et al. Poly(A)-Specific Ribonuclease Mediates 3′-End Trimming of Argonaute2-Cleaved 
Precursor MicroRNAs. Cell Rep. 5, 715–726 (2013). 
61. Heo, I. et al. Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-
7 MicroRNAs. Cell 151, 521–532 (2012). 
62. Fromont-Racine, M., Senger, B., Saveanu, C. & Fasiolo, F. Ribosome assembly in eukaryotes. 
Gene 313, 17–42 (2003). 
63. Tschochner, H. & Hurt, E. Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends 
Cell Biol. 13, 255–63 (2003). 
64. Fatica, A. & Tollervey, D. Making ribosomes. Curr. Opin. Cell Biol. 14, 313–8 (2002). 
65. Rouquette, J., Choesmel, V. & Gleizes, P.-E. Nuclear export and cytoplasmic processing of 
precursors to the 40S ribosomal subunits in mammalian cells. EMBO J. 24, 2862–2872 (2005). 
66. Schäfer, T., Strauss, D., Petfalski, E., Tollervey, D. & Hurt, E. The path from nucleolar 90S to 
cytoplasmic 40S pre-ribosomes. EMBO J. 22, 1370–80 (2003). 
67. Ferreira-Cerca, S., Pöll, G., Gleizes, P.-E., Tschochner, H. & Milkereit, P. Roles of Eukaryotic 
Ribosomal Proteins in Maturation and Transport of Pre-18S rRNA and Ribosome Function. Mol. 
Cell 20, 263–275 (2005). 
68. Moy, T. I. & Silver, P. A. Nuclear export of the small ribosomal subunit requires the ran-GTPase 
cycle and certain nucleoporins. Genes Dev. 13, 2118–33 (1999). 
69. Trotta, C. R., Lund, E., Kahan, L., Johnson, A. W. & Dahlberg, J. E. Coordinated nuclear export 
of 60S ribosomal subunits and NMD3 in vertebrates. EMBO J. 22, 2841–51 (2003). 
70. Thomas, F. & Kutay, U. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes 
depend on the CRM1 export pathway. J. Cell Sci. 116, (2003). 
71. Gadal, O. et al. Nuclear export of 60s ribosomal subunits depends on Xpo1p and requires a nuclear 
export sequence-containing factor, Nmd3p, that associates with the large subunit protein Rpl10p. 
Mol. Cell. Biol. 21, 3405–15 (2001). 
72. Ho, J. H., Kallstrom, G. & Johnson, A. W. Nmd3p is a Crm1p-dependent adapter protein for 
nuclear export of the large ribosomal subunit. J. Cell Biol. 151, 1057–66 (2000). 
73. Stage-Zimmermann, T., Schmidt, U. & Silver, P. A. Factors affecting nuclear export of the 60S 
ribosomal subunit in vivo. Mol. Biol. Cell 11, 3777–89 (2000). 
74. Hurt, E. et al. A novel in vivo assay reveals inhibition of ribosomal nuclear export in ran-cycle and 
nucleoporin mutants. J. Cell Biol. 144, 389–401 (1999). 
75. Nissan, T. A., Bassler, J., Petfalski, E., Tollervey, D. & Hurt, E. 60S pre-ribosome formation 
viewed from assembly in the nucleolus until export to the cytoplasm. EMBO J. 21, 5539–47 
(2002). 
76. West, M., Hedges, J. B., Chen, A. & Johnson, A. W. Defining the order in which Nmd3p and 
Rpl10p load onto nascent 60S ribosomal subunits. Mol. Cell. Biol. 25, 3802–13 (2005). 
77. Hedges, J., West, M. & Johnson, A. W. Release of the export adapter, Nmd3p, from the 60S 
ribosomal subunit requires Rpl10p and the cytoplasmic GTPase Lsg1p. EMBO J. 24, 567–579 
(2005). 
78. Lebreton, A. et al. A functional network involved in the recycling of nucleocytoplasmic pre-60S 
REFERENCES 
 
141 | P a g e  
 
factors. J. Cell Biol. 173, 349–60 (2006). 
79. Hung, N.-J. & Johnson, A. W. Nuclear Recycling of the Pre-60S Ribosomal Subunit-Associated 
Factor Arx1 Depends on Rei1 in Saccharomyces cerevisiae. Mol. Cell. Biol. 26, 3718–3727 (2006). 
80. Belaya, K., Tollervey, D. & Kos, M. FLIPing heterokaryons to analyze nucleo-cytoplasmic 
shuttling of yeast proteins. RNA 12, 921–30 (2006). 
81. Bradatsch, B. et al. Arx1 functions as an unorthodox nuclear export receptor for the 60S 
preribosomal subunit. Mol. Cell 27, 767–79 (2007). 
82. Squatrito, M., Mancino, M., Donzelli, M., Areces, L. B. & Draetta, G. F. EBP1 is a nucleolar 
growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. Oncogene 
23, 4454–4465 (2004). 
83. Matera, A. G., Terns, R. M. & Terns, M. P. Non-coding RNAs: lessons from the small nuclear 
and small nucleolar RNAs. Nat Rev Mol Cell Biol 8, 209–220 (2007). 
84. Hernandez, N. Small nuclear RNA genes: a model system to study fundamental mechanisms of 
transcription. J. Biol. Chem. 276, 26733–6 (2001). 
85. Kunkel, G. R., Maser, R. L., Calvet, J. P. & Pederson, T. U6 small nuclear RNA is transcribed 
by RNA polymerase III. Proc. Natl. Acad. Sci. U. S. A. 83, 8575–9 (1986). 
86. Schramm, L. & Hernandez, N. Recruitment of RNA polymerase III to its target promoters. Genes 
Dev. 16, 2593–620 (2002). 
87. Matera, A. G. & Wang, Z. A day in the life of the spliceosome. Nat. Rev. Mol. Cell Biol. 15, 108–
21 (2014). 
88. Yong, J., Wan, L. & Dreyfuss, G. Why do cells need an assembly machine for RNA–protein 
complexes? Trends Cell Biol. 14, 226–232 (2004). 
89. Hamm, J. et al. Monomethylated cap structures facilitate RNA export from the nucleus. Cell 63, 
109–18 (1990). 
90. Medlin, J. E., Uguen, P., Taylor, A., Bentley, D. L. & Murphy, S. The C-terminal domain of pol 
II and a DRB-sensitive kinase are required for 3’ processing of U2 snRNA. EMBO J. 22, 925–934 
(2003). 
91. Cuello, P., Boyd, D. C., Dye, M. J., Proudfoot, N. J. & Murphy, S. Transcription of the human 
U2 snRNA genes continues beyond the 3Ј box in vivo. EMBO J. 18, 2867–2877 (1999). 
92. Suzuki, T., Izumi, H. & Ohno, M. Cajal body surveillance of U snRNA export complex assembly. 
J. Cell Biol. 190, 603–12 (2010). 
93. Ohno, M., Segref, A., Bachi, A., Wilm, M. & Mattaj, I. W. PHAX, a Mediator of U snRNA 
Nuclear Export Whose Activity Is Regulated by Phosphorylation. Cell 101, 187–198 (2000). 
94. Izaurralde, E. et al. A cap-binding protein complex mediating U snRNA export. Nature 376, 709–
12 (1995). 
95. Segref, A., Mattaj, I. W. & Ohno, M. The evolutionarily conserved region of the U snRNA export 
mediator PHAX is a novel RNA-binding domain that is essential for U snRNA export. RNA 7, 
351–60 (2001). 
96. Mouaikel, J., Verheggen, C., Bertrand, E., Tazi, J. & Bordonné, R. Hypermethylation of the cap 
structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is 
localized to the nucleolus. Mol. Cell 9, 891–901 (2002). 
97. Huang, Q. & Pederson, T. A human U2 RNA mutant stalled in 3’ end processing is impaired in 
REFERENCES 
 
142 | P a g e  
 
nuclear import. Nucleic Acids Res. 27, 1025–1031 (1999). 
98. Huber, J. et al. Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain 
structure. EMBO J. 17, 4114–4126 (1998). 
99. Narayanan, U., Achsel, T., Lührmann, R. & Matera, A. G. Coupled In Vitro Import of U snRNPs 
and SMN, the Spinal Muscular Atrophy Protein. Mol. Cell 16, 223–234 (2004). 
100. Palacios, I., Hetzer, M., Adam, S. A. & Mattaj, I. W. Nuclear import of U snRNPs requires 
importin beta. EMBO J. 16, 6783–92 (1997). 
101. Matera, A. G. & Shpargel, K. B. Pumping RNA: nuclear bodybuilding along the RNP pipeline. 
Curr. Opin. Cell Biol. 18, 317–324 (2006). 
102. Sleeman, J. E. & Lamond, A. I. Newly assembled snRNPs associate with coiled bodies before 
speckles, suggesting a nuclear snRNP maturation pathway. Curr. Biol. 9, 1065–1074 (1999). 
103. Stanĕk, D., Rader, S. D., Klingauf, M. & Neugebauer, K. M. Targeting of U4/U6 small nuclear 
RNP assembly factor SART3/p110 to Cajal bodies. J. Cell Biol. 160, 505–16 (2003). 
104. Nesic, D. A role for Cajal bodies in the final steps of U2 snRNP biogenesis. J. Cell Sci. (2004). 
doi:10.1242/jcs.01308 
105. Schaffert, N., Hossbach, M., Heintzmann, R., Achsel, T. & Lührmann, R. RNAi knockdown of 
hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies. EMBO J. 23, 3000–9 
(2004). 
106. Stanĕk, D. & Neugebauer, K. M. Detection of snRNP assembly intermediates in Cajal bodies by 
fluorescence resonance energy transfer. J. Cell Biol. 166, 1015–25 (2004). 
107. Decroly, E., Ferron, F., Lescar, J. & Canard, B. Conventional and unconventional mechanisms 
for capping viral mRNA. Nat. Rev. Microbiol. 10, 51–65 (2011). 
108. Egloff, S. & Murphy, S. Cracking the RNA polymerase II CTD code. Trends Genet. 24, 280–288 
(2008). 
109. Topisirovic, I., Svitkin, Y. V, Sonenberg, N. & Shatkin, A. J. Cap and cap-binding proteins in the 
control of gene expression. Wiley Interdiscip. Rev. RNA 2, 277–98 (2011). 
110. Ramanathan, A., Robb, G. B. & Chan, S. H. mRNA capping: Biological functions and applications. 
Nucleic Acids Res. 44, 7511–7526 (2016). 
111. Cowling, V. H. & Cole, M. D. Regulation of mRNA Cap Methylation. Genes Cancer 1, 576–579 
(2010). 
112. Gonatopoulos-Pournatzis, T. & Cowling, V. H. Cap-binding complex (CBC). Biochem. J. 457, 
231–42 (2014). 
113. Daffis, S. et al. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family 
members. Nature 468, 452–456 (2010). 
114. Ohno, M. Size matters in RNA export. RNA Biol. 9, 1413–7 (2012). 
115. Masuyama, K., Taniguchi, I., Kataoka, N. & Ohno, M. RNA length defines RNA export pathway. 
Genes Dev. 18, 2074–85 (2004). 
116. König, J. et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide 
resolution. Nat. Struct. Mol. Biol. 17, 909–15 (2010). 
117. McAfee, J. G., Shahied-Milam, L., Soltaninassab, S. R. & LeStourgeon, W. M. A major 
determinant of hnRNP C protein binding to RNA is a novel bZIP-like RNA binding domain. RNA 
REFERENCES 
 
143 | P a g e  
 
2, 1139–52 (1996). 
118. Huang, M. et al. The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and nucleates 
the assembly of 40S heterogeneous nuclear ribonucleoprotein particles. Mol. Cell. Biol. 14, 518–
33 (1994). 
119. Weighardt, F., Biamonti, G. & Riva, S. The roles of heterogeneous nuclear ribonucleoproteins 
(hnRNP) in RNA metabolism. Bioessays 18, 747–56 (1996). 
120. Müller-McNicoll, M. & Neugebauer, K. M. How cells get the message: dynamic assembly and 
function of mRNA–protein complexes. Nat. Rev. Genet. 14, 275–287 (2013). 
121. Listerman, I., Sapra, A. K. & Neugebauer, K. M. Cotranscriptional coupling of splicing factor 
recruitment and precursor messenger RNA splicing in mammalian cells. Nat. Struct. Mol. Biol. 13, 
815–22 (2006). 
122. Wahl, M. C., Will, C. L. & Lührmann, R. The Spliceosome: Design Principles of a Dynamic RNP 
Machine. Cell 136, 701–718 (2009). 
123. Bentley, D. L. Rules of engagement: co-transcriptional recruitment of pre-mRNA processing 
factors. Curr. Opin. Cell Biol. 17, 251–6 (2005). 
124. Inoue, K., Ohno, M., Sakamoto, H. & Shimura, Y. Effect of the cap structure on pre-mRNA 
splicing in Xenopus oocyte nuclei. Genes Dev. 3, 1472–9 (1989). 
125. Izaurralde, E. et al. A nuclear cap binding protein complex involved in pre-mRNA splicing. Cell 
78, 657–668 (1994). 
126. Konarska, M. M., Padgett, R. A. & Sharp, P. A. Recognition of cap structure in splicing in vitro 
of mRNA precursors. Cell 38, 731–6 (1984). 
127. Edery, I. & Sonenberg, N. Cap-dependent RNA splicing in a HeLa nuclear extract. Proc. Natl. 
Acad. Sci. U. S. A. 82, 7590–4 (1985). 
128. Ohno, M., Sakamoto, H. & Shimura, Y. Preferential excision of the 5’ proximal intron from 
mRNA precursors with two introns as mediated by the cap structure. Proc. Natl. Acad. Sci. U. S. A. 
84, 5187–91 (1987). 
129. Patzelt, E., Thalmann, E., Hartmuth, K., Blaas, D. & Kuechler, E. Assembly of pre-mRNA 
splicing complex is cap dependent. Nucleic Acids Res. 15, 1387–99 (1987). 
130. Lewis, J. D., Izaurralde, E., Jarmolowski, A., McGuigan, C. & Mattaj, I. W. A nuclear cap-
binding complex facilitates association of U1 snRNP with the cap-proximal 5’ splice site. Genes 
Dev. 10, 1683–98 (1996). 
131. Pabis, M. et al. The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and 
promotes spliceosome assembly in mammalian cells. RNA 19, 1054–63 (2013). 
132. Jiao, X., Chang, J. H., Kilic, T., Tong, L. & Kiledjian, M. A Mammalian Pre-mRNA 5′ End 
Capping Quality Control Mechanism and an Unexpected Link of Capping to Pre-mRNA 
Processing. Mol. Cell 50, 104–115 (2013). 
133. Tange Thomas Øand Nott, A., Moore, M. J., Tange, T. Ø. & Nott, A. The ever-increasing 
complexities of the exon junction complex. Curr. Opin. Cell Biol. 16, 279–284 (2004). 
134. Le Hir, H., Izaurralde, E., Maquat, L. E. & Moore, M. J. The spliceosome deposits multiple 
proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 19, 6860–9 (2000). 
135. Chang, Y.-F., Imam, J. S. & Wilkinson, M. F. The nonsense-mediated decay RNA surveillance 
pathway. Annu. Rev. Biochem. 76, 51–74 (2007). 
REFERENCES 
 
144 | P a g e  
 
136. Alexandrov, A., Colognori, D., Shu, M.-D. & Steitz, J. A. Human spliceosomal protein CWC22 
plays a role in coupling splicing to exon junction complex deposition and nonsense-mediated 
decay. Proc. Natl. Acad. Sci. 109, 21313–21318 (2012). 
137. Barbosa, I. et al. Human CWC22 escorts the helicase eIF4AIII to spliceosomes and promotes exon 
junction complex assembly. Nat. Struct. Mol. Biol. 19, 983–90 (2012). 
138. Steckelberg, A.-L., Boehm, V., Gromadzka, A. M. & Gehring, N. H. CWC22 Connects Pre-
mRNA Splicing and Exon Junction Complex Assembly. Cell Rep. 2, 454–461 (2012). 
139. Steckelberg, A.-L., Altmueller, J., Dieterich, C. & Gehring, N. H. CWC22-dependent pre-
mRNA splicing and eIF4A3 binding enables global deposition of exon junction complexes. Nucleic 
Acids Res. 43, 4687–700 (2015). 
140. Bessonov, S., Anokhina, M., Will, C. L., Urlaub, H. & Lührmann, R. Isolation of an active step I 
spliceosome and composition of its RNP core. Nature 452, 846–850 (2008). 
141. Buchwald, G., Schüssler, S., Basquin, C., Le Hir, H. & Conti, E. Crystal structure of the human 
eIF4AIII-CWC22 complex shows how a DEAD-box protein is inhibited by a MIF4G domain. Proc. 
Natl. Acad. Sci. U. S. A. 110, E4611-8 (2013). 
142. Gehring, N. H., Lamprinaki, S., Hentze, M. W. & Kulozik, A. E. The hierarchy of exon-junction 
complex assembly by the spliceosome explains key features of mammalian nonsense-mediated 
mRNA decay. PLoS Biol. 7, e1000120 (2009). 
143. Andersen, C. B. F. et al. Structure of the Exon Junction Core Complex with a Trapped DEAD-
Box ATPase Bound to RNA. Science (80-. ). 313, 1968–1972 (2006). 
144. Ballut, L. et al. The exon junction core complex is locked onto RNA by inhibition of eIF4AIII 
ATPase activity. Nat. Struct. Mol. Biol. 12, 861–869 (2005). 
145. Nielsen, K. H. et al. Mechanism of ATP turnover inhibition in the EJC. RNA 15, 67–75 (2008). 
146. Bono, F., Ebert, J., Lorentzen, E. & Conti, E. The Crystal Structure of the Exon Junction 
Complex Reveals How It Maintains a Stable Grip on mRNA. Cell 126, 713–725 (2006). 
147. Merz, C., Urlaub, H., Will, C. L. & Lührmann, R. Protein composition of human mRNPs spliced 
in vitro and differential requirements for mRNP protein recruitment. RNA 13, 116–28 (2007). 
148. Singh, G. et al. The cellular EJC interactome reveals higher-order mRNP structure and an EJC-
SR protein nexus. Cell 151, 750–64 (2012). 
149. Tange, T. Ø., Shibuya, T., Jurica, M. S., Moore, M. J. & Tange Thomas Øand Shibuya, T. 
Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA 
11, 1869–1883 (2005). 
150. Schmidt, U. et al. Assembly and mobility of exon-exon junction complexes in living cells. RNA 15, 
862–76 (2009). 
151. Le Hir, H. & Andersen, G. R. Structural insights into the exon junction complex. Curr. Opin. 
Struct. Biol. 18, 112–9 (2008). 
152. Schwerk, C. et al. ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol. 
Cell. Biol. 23, 2981–90 (2003). 
153. Li, C., Lin, R.-I., Lai, M.-C., Ouyang, P. & Tarn, W.-Y. Nuclear Pnn/DRS protein binds to 
spliced mRNPs and participates in mRNA processing and export via interaction with RNPS1. Mol. 
Cell. Biol. 23, 7363–76 (2003). 
154. Murachelli, A. G., Ebert, J., Basquin, C., Le Hir, H. & Conti, E. The structure of the ASAP core 
REFERENCES 
 
145 | P a g e  
 
complex reveals the existence of a Pinin-containing PSAP complex. Nat. Struct. Mol. Biol. 19, 378–
86 (2012). 
155. Schmidt, C. et al. Mass spectrometry-based relative quantification of proteins in precatalytic and 
catalytically active spliceosomes by metabolic labeling (SILAC), chemical labeling (iTRAQ), and 
label-free spectral count. RNA 20, 406–420 (2014). 
156. Boehm, V. & Gehring, N. H. Exon Junction Complexes : Supervising the Gene Expression 
Assembly Line. Trends Genet. 32, 724–735 (2016). 
157. Chan, C. C. et al. eIF4A3 is a novel component of the exon junction complex. RNA 10, 200–9 
(2004). 
158. Degot, S. et al. Association of the breast cancer protein MLN51 with the exon junction complex 
via its speckle localizer and RNA binding module. J. Biol. Chem. 279, 33702–15 (2004). 
159. Ferraiuolo, M. A. et al. A nuclear translation-like factor eIF4AIII is recruited to the mRNA during 
splicing and functions in nonsense-mediated decay. Proc. Natl. Acad. Sci. U. S. A. 101, 4118–23 
(2004). 
160. Gatfield, D. & Izaurralde, E. REF1/Aly and the additional exon junction complex proteins are 
dispensable for nuclear mRNA export. J. Cell Biol. 159, 579–88 (2002). 
161. Kataoka, N. et al. Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding 
protein that persists in the cytoplasm. Mol. Cell 6, 673–82 (2000). 
162. Kataoka, N., Diem, M. D., Kim, V. N., Yong, J. & Dreyfuss, G. Magoh, a human homolog of 
Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction 
complex. EMBO J. 20, 6424–33 (2001). 
163. Le Hir, H., Gatfield, D., Braun, I. C., Forler, D. & Izaurralde, E. The protein Mago provides a 
link between splicing and mRNA localization. EMBO Rep. 2, 1119–24 (2001). 
164. Le Hir, H., Gatfield, D., Izaurralde, E. & Moore, M. J. The exon-exon junction complex provides 
a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. 
EMBO J. 20, 4987–97 (2001). 
165. Luo, M.-J. L. et al. Pre-mRNA splicing and mRNA export linked by direct interactions between 
UAP56 and Aly. Nature 413, 644–7 (2001). 
166. Lykke-Andersen, J., Shu, M. D. & Steitz, J. A. Human Upf proteins target an mRNA for 
nonsense-mediated decay when bound downstream of a termination codon. Cell 103, 1121–31 
(2000). 
167. Lykke-Andersen, J., Shu, M. D. & Steitz, J. A. Communication of the position of exon-exon 
junctions to the mRNA surveillance machinery by the protein RNPS1. Science 293, 1836–9 (2001). 
168. Palacios, I. M., Gatfield, D., St Johnston, D. & Izaurralde, E. An eIF4AIII-containing complex 
required for mRNA localization and nonsense-mediated mRNA decay. Nature 427, 753–7 (2004). 
169. Shibuya, T., Tange, T. Ø., Sonenberg, N. & Moore, M. J. eIF4AIII binds spliced mRNA in the 
exon junction complex and is essential for nonsense-mediated decay. Nat. Struct. Mol. Biol. 11, 
346–51 (2004). 
170. Zhou, Z. et al. The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. 
Nature 407, 401–5 (2000). 
171. Valencia, P., Dias, A. P. & Reed, R. Splicing promotes rapid and efficient mRNA export in 
mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 105, 3386–91 (2008). 
REFERENCES 
 
146 | P a g e  
 
172. Masuda, S. et al. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 
19, 1512–7 (2005). 
173. Rodríguez-Navarro, S. & Hurt, E. Linking gene regulation to mRNA production and export. Curr. 
Opin. Cell Biol. 23, 302–9 (2011). 
174. Strässer, K. et al. TREX is a conserved complex coupling transcription with messenger RNA 
export. Nature 417, 304–8 (2002). 
175. Dufu, K. et al. ATP is required for interactions between UAP56 and two conserved mRNA export 
proteins, Aly and CIP29, to assemble the TREX complex. Genes Dev. 24, 2043–53 (2010). 
176. Folco, E. G., Lee, C.-S., Dufu, K., Yamazaki, T. & Reed, R. The proteins PDIP3 and ZC11A 
associate with the human TREX complex in an ATP-dependent manner and function in mRNA 
export. PLoS One 7, e43804 (2012). 
177. Chang, C.-T. et al. Chtop is a component of the dynamic TREX mRNA export complex. EMBO J. 
32, 473–86 (2013). 
178. Hautbergue, G. M. et al. UIF, a New mRNA export adaptor that works together with REF/ALY, 
requires FACT for recruitment to mRNA. Curr. Biol. 19, 1918–24 (2009). 
179. Viphakone, N. et al. Luzp4 defines a new mRNA export pathway in cancer cells. Nucleic Acids Res. 
43, 2353–2366 (2015). 
180. Yamazaki, T. et al. The Closely Related RNA helicases, UAP56 and URH49, Preferentially Form 
Distinct mRNA Export Machineries and Coordinately Regulate Mitotic Progression. Mol. Biol. Cell 
21, 2953–2965 (2010). 
181. Cheng, H. et al. Human mRNA export machinery recruited to the 5’ end of mRNA. Cell 127, 
1389–400 (2006). 
182. Viphakone, N. et al. TREX exposes the RNA-binding domain of Nxf1 to enable mRNA export. 
Nat. Commun. 3, 1006 (2012). 
183. Hautbergue, G. M., Hung, M.-L. M.-L., Golovanov, A. P., Lian, L.-Y. & Wilson, S. A. Mutually 
exclusive interactions drive handover of mRNA from export adaptors to TAP. Proc. Natl. Acad. 
Sci. U. S. A. 105, 5154–9 (2008). 
184. Proudfoot, N. J. Ending the message: poly(A) signals then and now. Genes Dev. 25, 1770–82 
(2011). 
185. Proudfoot, N. J., Furger, A. & Dye, M. J. Integrating mRNA Processing with Transcription. Cell 
108, 501–512 (2002). 
186. Eckmann, C. R., Rammelt, C. & Wahle, E. Control of poly(A) tail length. Wiley Interdiscip. Rev. 
RNA 2, 348–361 (2011). 
187. Johnson, S. A., Kim, H., Erickson, B. & Bentley, D. L. The export factor Yra1 modulates mRNA 
3’ end processing. Nat. Struct. Mol. Biol. 18, 1164–71 (2011). 
188. Katahira, J. et al. Human TREX component Thoc5 affects alternative polyadenylation site choice 
by recruiting mammalian cleavage factor I. Nucleic Acids Res. 41, 7060–7072 (2013). 
189. Tran, D. D. H. et al. THOC5 controls 3′end-processing of immediate early genes via interaction 
with polyadenylation specific factor 100 (CPSF100). Nucleic Acids Res. 42, 12249–12260 (2014). 
190. Lou, H., Neugebauer, K. M., Gagel, R. F. & Berget, S. M. Regulation of alternative 
polyadenylation by U1 snRNPs and SRp20. Mol. Cell. Biol. 18, 4977–85 (1998). 
191. Proudfoot, N. J. Ending the message: poly(A) signals then and now. Genes Dev. 25, 1770–1782 
REFERENCES 
 
147 | P a g e  
 
(2011). 
192. Berg, M. G. et al. U1 snRNP Determines mRNA Length and Regulates Isoform Expression. Cell 
150, 53–64 (2012). 
193. Kaida, D. et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. 
Nature 468, 664–668 (2010). 
194. Ruepp, M.-D., Schümperli, D. & Barabino, S. M. L. mRNA 3′ end processing and more-multiple 
functions of mammalian cleavage factor I-68. Wiley Interdiscip. Rev. RNA 2, 79–91 (2011). 
195. Li, Y. et al. An intron with a constitutive transport element is retained in a Tap messenger RNA. 
Nature 443, 234–237 (2006). 
196. Segref, A. et al. Mex67p, a novel factor for nuclear mRNA export, binds to both poly(A)+ RNA 
and nuclear pores. EMBO J. 16, 3256–3271 (1997). 
197. Grüter, P. et al. TAP, the Human Homolog of Mex67p, Mediates CTE-Dependent RNA Export 
from the Nucleus. Mol. Cell 1, 649–659 (1998). 
198. Katahira, J. et al. The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast 
to human. EMBO J. 18, 2593–2609 (1999). 
199. Katahira, J. & Yoneda, Y. Roles of the TREX complex in nuclear export of mRNA ND ES OS NO 
ST ND ES OS NO. RNA Biol. 6, 149–152 (2009). 
200. Katahira, J. mRNA export and the TREX complex. Biochim. Biophys. Acta 1819, 507–13 (2012). 
201. Golovanov, A. P., Hautbergue, G. M., Tintaru, A. M., Lian, L.-Y. & Wilson, S. A. The solution 
structure of REF2-I reveals interdomain interactions and regions involved in binding mRNA 
export factors and RNA. RNA 12, 1933–48 (2006). 
202. Okamura, M., Inose, H. & Masuda, S. RNA Export through the NPC in Eukaryotes. Genes (Basel). 
6, 124–149 (2015). 
203. Wickramasinghe, V. O. et al. mRNA Export from Mammalian Cell Nuclei Is Dependent on 
GANP. Curr. Biol. 20, 25–31 (2010). 
204. Jani, D. et al. Functional and structural characterization of the mammalian TREX-2 complex that 
links transcription with nuclear messenger RNA export. Nucleic Acids Res. 40, 4562–73 (2012). 
205. Wickramasinghe, V. O., Stewart, M. & Laskey, R. A. GANP enhances the efficiency of mRNA 
nuclear export in mammalian cells. Nucleus 1, 393–396 (2010). 
206. Umlauf, D. et al. The human TREX-2 complex is stably associated with the nuclear pore basket. 
J. Cell Sci. 126, 2656–67 (2013). 
207. Wickramasinghe, V. O. et al. Selective nuclear export of specific classes of mRNA from 
mammalian nuclei is promoted by GANP. Nucleic Acids Res. 42, 1–13 (2014). 
208. Bachi, A. et al. The C-terminal domain of TAP interacts with the nuclear pore complex and 
promotes export of specific CTE-bearing RNA substrates. RNA 6, 136–58 (2000). 
209. Blevins, M. B., Smith, A. M., Phillips, E. M. & Powers, M. A. Complex Formation among the 
RNA Export Proteins Nup98, Rae1/Gle2, and TAP. J. Biol. Chem. 278, 20979–20988 (2003). 
210. Mor, A. et al. Dynamics of single mRNP nucleocytoplasmic transport and export through the 
nuclear pore in living cells. Nat. Cell Biol. 12, 543–552 (2010). 
211. Sheinberger, J. & Shav-Tal, Y. The dynamic pathway of nuclear RNA in eukaryotes. Nucleus 4, 
195–205 (2013). 
REFERENCES 
 
148 | P a g e  
 
212. Oeffinger, M. & Zenklusen, D. To the pore and through the pore: A story of mRNA export 
kinetics. Biochim. Biophys. Acta - Gene Regul. Mech. 1819, 494–506 (2012). 
213. Ben-Ari, Y. et al. The life of an mRNA in space and time. J. Cell Sci. 123, (2010). 
214. Movement of nuclear poly(A) RNA throughout the interchromatin space in living cells. Curr. Biol. 
9, 285–291 (1999). 
215. Shav-Tal, Y. et al. Dynamics of single mRNPs in nuclei of living cells. Science 304, 1797–800 
(2004). 
216. Krull, S. et al. Protein Tpr is required for establishing nuclear pore-associated zones of 
heterochromatin exclusion. EMBO J. 29, 1659–1673 (2010). 
217. Shibata, S., Matsuoka, Y. & Yoneda, Y. Nucleocytoplasmic transport of proteins and poly(A)+ 
RNA in reconstituted Tpr-less nuclei in living mammalian cells. Genes Cells 7, 421–34 (2002). 
218. Wu, J., Matunis, M. J., Kraemer, D., Blobel, G. & Coutavas, E. Nup358, a cytoplasmically 
exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A 
homologous domain, and a leucine-rich region. J. Biol. Chem. 270, 14209–13 (1995). 
219. Forler, D. et al. RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the 
nuclear pore complex and functions in nuclear mRNA export. Mol. Cell. Biol. 24, 1155–67 (2004). 
220. Bernad, R., van der Velde, H., Fornerod, M. & Pickersgill, H. Nup358/RanBP2 attaches to the 
nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role 
in CRM1-mediated nuclear protein export. Mol. Cell. Biol. 24, 2373–84 (2004). 
221. Wickramasinghe, V. O. & Laskey, R. A. Control of mammalian gene expression by selective 
mRNA export. Nat. Rev. Mol. Cell Biol. 16, 431–442 (2015). 
222. Katahira, J., Inoue, H., Hurt, E. & Yoneda, Y. Adaptor Aly and co-adaptor Thoc5 function in the 
Tap-p15-mediated nuclear export of HSP70 mRNA. EMBO J. 28, 556–67 (2009). 
223. Wang, L. et al. The THO Complex Regulates Pluripotency Gene mRNA Export and Controls 
Embryonic Stem Cell Self-Renewal and Somatic Cell Reprogramming. Cell Stem Cell 13, 676–690 
(2013). 
224. Huang, Y., Gattoni, R., Stévenin, J. & Steitz, J. A. SR splicing factors serve as adapter proteins 
for TAP-dependent mRNA export. Mol. Cell 11, 837–43 (2003). 
225. Long, J. C. & Caceres, J. F. The SR protein family of splicing factors: master regulators of gene 
expression. Biochem. J. 417, 15–27 (2009). 
226. Huang, Y. & Steitz, J. A. SRprises along a Messenger’s Journey. Mol. Cell 17, 613–615 (2005). 
227. Wickramasinghe, V. O. et al. Human Inositol Polyphosphate Multikinase Regulates Transcript-
Selective Nuclear mRNA Export to Preserve Genome Integrity. Mol. Cell 51, 737–750 (2013). 
228. Smulevitch, S. et al. RTE and CTE mRNA export elements synergistically increase expression of 
unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology 3, 6 (2006). 
229. Lindtner, S. et al. RNA-binding Motif Protein 15 Binds to the RNA Transport Element RTE and 
Provides a Direct Link to the NXF1 Export Pathway. J. Biol. Chem. 281, 36915–36928 (2006). 
230. Aibara, S., Katahira, J., Valkov, E. & Stewart, M. The principal mRNA nuclear export factor 
NXF1:NXT1 forms a symmetric binding platform that facilitates export of retroviral CTE-RNA. 
Nucleic Acids Res. 43, 1883–93 (2015). 
231. Kraut-Cohen, J. & Gerst, J. E. Addressing mRNAs to the ER: cis sequences act up! Trends Biochem. 
Sci. 35, 459–469 (2010). 
REFERENCES 
 
149 | P a g e  
 
232. Palazzo, A. F. et al. The Signal Sequence Coding Region Promotes Nuclear Export of mRNA. PLoS 
Biol. 5, e322 (2007). 
233. Faria, A. M. C. et al. The nucleoporin Nup96 is required for proper expression of interferon-
regulated proteins and functions. Immunity 24, 295–304 (2006). 
234. Chakraborty, P. et al. Nucleoporin Levels Regulate Cell Cycle Progression and Phase-Specific 
Gene Expression. Dev. Cell 15, 657–667 (2008). 
235. Peng, S. S., Chen, C. Y., Xu, N. & Shyu, A. B. RNA stabilization by the AU-rich element binding 
protein, HuR, an ELAV protein. EMBO J. 17, 3461–70 (1998). 
236. Brennan, C. M., Gallouzi, I. E. & Steitz, J. A. Protein ligands to HuR modulate its interaction 
with target mRNAs in vivo. J. Cell Biol. 151, 1–14 (2000). 
237. Barreau, C., Paillard, L. & Osborne, H. B. AU-rich elements and associated factors: are there 
unifying principles? Nucleic Acids Res. 33, 7138–7150 (2005). 
238. Fries, B. et al. Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its 
Influence on CD83 Expression. J. Biol. Chem. 282, 4504–4515 (2007). 
239. Kimura, T., Hashimoto, I., Nagase, T. & Fujisawa, J.-I. CRM1-dependent, but not ARE-
mediated, nuclear export of IFN- 1 mRNA. J. Cell Sci. 117, 2259–2270 (2004). 
240. Hodge, D. L. et al. IFN-gamma AU-rich element removal promotes chronic IFN-gamma 
expression and autoimmunity in mice. J. Autoimmun. 53, 33–45 (2014). 
241. Yang, J., Bogerd, H. P., Wang, P. J., Page, D. C. & Cullen, B. R. Two closely related human 
nuclear export factors utilize entirely distinct export pathways. Mol. Cell 8, 397–406 (2001). 
242. Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M. & Borden, K. L. B. B. eIF4E is 
a central node of an RNA regulon that governs cellular proliferation. J. Cell Biol. 175, 415–26 
(2006). 
243. Topisirovic, I. et al. Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-
competent RNP. EMBO J. 28, 1087–98 (2009). 
244. Culjkovic-Kraljacic, B. et al. Combinatorial targeting of nuclear export and translation of RNA 
inhibits aggressive B-cell lymphomas. Blood 127, 858–868 (2016). 
245. Culjkovic, B. & Borden, K. L. Understanding and Targeting the Eukaryotic Translation Initiation 
Factor eIF4E in Head and Neck Cancer. J. Oncol. 2009, 1–12 (2009). 
246. Culjkovic-Kraljacic, B., Baguet, A., Volpon, L., Amri, A. & Borden, K. L. B. The Oncogene 
eIF4E Reprograms the Nuclear Pore Complex to Promote mRNA Export and Oncogenic 
Transformation. Cell Rep. 2, 207–215 (2012). 
247. Mettenleiter, T. C., Müller, F., Granzow, H. & Klupp, B. G. The way out: what we know and 
do not know about herpesvirus nuclear egress. Cell. Microbiol. 15, 170–178 (2013). 
248. Mettenleiter, T. C. Herpesvirus assembly and egress. J. Virol. 76, 1537–47 (2002). 
249. Speese, S. D. et al. Nuclear Envelope Budding Enables Large Ribonucleoprotein Particle Export 
during Synaptic Wnt Signaling. Cell 149, 832–846 (2012). 
250. Hatch, E. & Hetzer, M. Breaching the nuclear envelope in development and disease. J. Cell Biol. 
205, 133–141 (2014). 
251. Montpetit, B. & Weis, K. Cell biology. An alternative route for nuclear mRNP export by 
membrane budding. Science 336, 809–10 (2012). 
252. Samji, T. Influenza A: understanding the viral life cycle. Yale J. Biol. Med. 82, 153–9 (2009). 
REFERENCES 
 
150 | P a g e  
 
253. von Appen, A. & Beck, M. Structure Determination of the Nuclear Pore Complex with Three-
Dimensional Cryo electron Microscopy. J. Mol. Biol. 428, 2001–10 (2016). 
254. Gao, S. et al. Characteristics of Nucleocytoplasmic Transport of H1N1 Influenza A Virus Nuclear 
Export Protein. J. Virol. 88, 7455–7463 (2014). 
255. Mühlbauer, D. et al. Influenza Virus-Induced Caspase-Dependent Enlargement of Nuclear Pores 
Promotes Nuclear Export of Viral Ribonucleoprotein Complexes. J. Virol. 89, 6009–6021 (2015). 
256. Rivas, H. G., Schmaling, S. K. & Gaglia, M. M. Shutoff of host gene expression in influenza A 
virus and herpesviruses: Similar mechanisms and common themes. Viruses 8, 1–26 (2016). 
257. Bercovich-Kinori, A. et al. A systematic view on influenza induced host shutoff. Elife 5, 1–12 
(2016). 
258. Yarbrough, M. L., Mata, M. A., Sakthivel, R. & Fontoura, B. M. A. Viral Subversion of 
Nucleocytoplasmic Trafficking. Traffic 15, 127–140 (2014). 
259. Krug, R. M. Functions of the influenza A virus NS1 protein in antiviral defense. Curr. Opin. Virol. 
12, 1–6 (2015). 
260. Hale, B. G., Randall, R. E., Ortin, J. & Jackson, D. The multifunctional NS1 protein of influenza 
A viruses. J. Gen. Virol. 89, 2359–2376 (2008). 
261. García-Sastre, A. et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient 
systems. Virology 252, 324–30 (1998). 
262. Egorov, A. et al. Transfectant influenza A viruses with long deletions in the NS1 protein grow 
efficiently in Vero cells. J. Virol. 72, 6437–41 (1998). 
263. Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M. Influenza virus NS1 protein 
interacts with the cellular 30 kDa subunit of CPSF and inhibits 3’end formation of cellular pre-
mRNAs. Mol. Cell 1, 991–1000 (1998). 
264. Chen, Z., Li, Y. & Krug, R. M. Influenza A virus NS1 protein targets poly(A)-binding protein II 
of the cellular 3’-end processing machinery. EMBO J. 18, 2273–2283 (1999). 
265. Satterly, N. et al. Influenza virus targets the mRNA export machinery and the nuclear pore 
complex. Proc. Natl. Acad. Sci. 104, 1853–1858 (2007). 
266. Kuss, S. K., Mata, M. a, Zhang, L. & Fontoura, B. M. a. Nuclear imprisonment: viral strategies 
to arrest host mRNA nuclear export. Viruses 5, 1824–49 (2013). 
267. Kainov, D. E. et al. Differential Effects of NS1 Proteins of Human Pandemic H1N1/2009, Avian 
Highly Pathogenic H5N1, and Low Pathogenic H5N2 Influenza A Viruses on Cellular Pre-mRNA 
Polyadenylation and mRNA Translation. J. Biol. Chem. 286, 7239–7247 (2011). 
268. Hale, B. G. et al. Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 
Influenza A Virus NS1 Protein. J. Virol. 84, 6909–6922 (2010). 
269. Kochs, G., García-Sastre, A. & Martínez-Sobrido, L. Multiple anti-interferon actions of the 
influenza A virus NS1 protein. J. Virol. 81, 7011–21 (2007). 
270. Ayllon, J. et al. A Single Amino Acid Substitution in the Novel H7N9 Influenza A Virus NS1 
Protein Increases CPSF30 Binding and Virulence. J. Virol. 88, 12146–12151 (2014). 
271. Twu, K. Y., Kuo, R.-L., Marklund, J. & Krug, R. M. The H5N1 Influenza Virus NS Genes 
Selected after 1998 Enhance Virus Replication in Mammalian Cells. J. Virol. 81, 8112–8121 
(2007). 
272. Poon, L. L., Pritlove, D. C., Fodor, E. & Brownlee, G. G. Direct evidence that the poly(A) tail 
REFERENCES 
 
151 | P a g e  
 
of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA 
template. J. Virol. 73, 3473–6 (1999). 
273. Firth, A. E. et al. Ribosomal frameshifting used in influenza A virus expression occurs within the 
sequence UCC_UUU_CGU and is in the +1 direction. Open Biol. 2, 120109 (2012). 
274. Jagger, B. W. et al. An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 
Modulates the Host Response. Science (80-. ). 337, 199–204 (2012). 
275. Dias, A. et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA 
subunit. Nature 458, 914–918 (2009). 
276. Yuan, P. et al. Crystal structure of an avian influenza polymerase PAN reveals an endonuclease 
active site. Nature 458, 909–913 (2009). 
277. Oishi, K., Yamayoshi, S. & Kawaoka, Y. Mapping of a Region of the PA-X Protein of Influenza A 
Virus That Is Important for Its Shutoff Activity. J. Virol. 89, 8661–8665 (2015). 
278. Sun, Y. et al. Twenty amino acids at the C-terminus of PA-X are associated with increased 
influenza A virus replication and pathogenicity. J. Gen. Virol. 96, 2036–2049 (2015). 
279. Hayashi, T., MacDonald, L. A. & Takimoto, T. Influenza A Virus Protein PA-X Contributes to 
Viral Growth and Suppression of the Host Antiviral and Immune Responses. J. Virol. 89, 6442–
6452 (2015). 
280. Gao, H. et al. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly 
pathogenic H5N1 avian influenza viruses. Sci. Rep. 5, 8262 (2015). 
281. Hu, J. et al. PA-X Decreases the Pathogenicity of Highly Pathogenic H5N1 Influenza A Virus in 
Avian Species by Inhibiting Virus Replication and Host Response. J. Virol. 89, 4126–4142 (2015). 
282. Khaperskyy, D. A., Schmaling, S., Larkins-Ford, J., McCormick, C. & Gaglia, M. M. Selective 
Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff 
Protein. PLOS Pathog. 12, e1005427 (2016). 
283. Khaperskyy, D. A. et al. Influenza A Virus Host Shutoff Disables Antiviral Stress-Induced 
Translation Arrest. PLoS Pathog. 10, e1004217 (2014). 
284. von Kobbe C et al. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by 
targeting the nucleoporin Nup98. Mol. Cell 6, 1243–52 (2000). 
285. Faria, P. A. et al. VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export Pathway. Mol. Cell 17, 
93–102 (2005). 
286. Quan, B., Seo, H.-S., Blobel, G. & Ren, Y. Vesiculoviral matrix (M) protein occupies nucleic acid 
binding site at nucleoporin pair (Rae1•Nup98). doi:10.1073/pnas.1409076111 
287. Petersen, J. M., Her, L. S., Varvel, V., Lund, E. & Dahlberg, J. E. The matrix protein of vesicular 
stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with 
nuclear pore complexes. Mol. Cell. Biol. 20, 8590–601 (2000). 
288. Castello, A., Izquierdo, J. M., Welnowska, E. & Carrasco, L. RNA nuclear export is blocked by 
poliovirus 2A protease and is concomitant with nucleoporin cleavage. J. Cell Sci. 122, 3799–3809 
(2009). 
289. Enninga, J., Levy, D. E., Blobel, G. & Fontoura, B. M. A. Role of Nucleoporin Induction in 
Releasing an mRNA Nuclear Export Block. Science (80-. ). 295, 1523–1525 (2002). 
290. Rajani, K. R. et al. Complexes of Vesicular Stomatitis Virus Matrix Protein with Host Rae1 and 
Nup98 Involved in Inhibition of Host Transcription. PLoS Pathog. 8, e1002929 (2012). 
REFERENCES 
 
152 | P a g e  
 
291. Kalverda, B., Pickersgill, H., Shloma, V. V. & Fornerod, M. Nucleoporins Directly Stimulate 
Expression of Developmental and Cell-Cycle Genes Inside the Nucleoplasm. Cell 140, 360–371 
(2010). 
292. Capelson, M. et al. Chromatin-Bound Nuclear Pore Components Regulate Gene Expression in 
Higher Eukaryotes. Cell 140, 372–383 (2010). 
293. Blower, M. D., Nachury, M., Heald, R. & Weis, K. A Rae1-Containing Ribonucleoprotein 
Complex Is Required for Mitotic Spindle Assembly. Cell 121, 223–234 (2005). 
294. Cross, M. K. & Powers, M. A. Nup98 regulates bipolar spindle assembly through association with 
microtubules and opposition of MCAK. Mol. Biol. Cell 22, 661–672 (2011). 
295. Chakraborty, P. et al. Vesicular stomatitis virus inhibits mitotic progression and triggers cell death. 
EMBO Rep. 10, 1154–1160 (2009). 
296. Hastie, E. & Grdzelishvili, V. Z. Vesicular stomatitis virus as a flexible platform for oncolytic 
virotherapy against cancer. J. Gen. Virol. 93, 2529–2545 (2012). 
297. te Velthuis, A. J. W. & Fodor, E. Influenza virus RNA polymerase: insights into the mechanisms 
of viral RNA synthesis. Nat. Rev. Microbiol. 14, 479–493 (2016). 
298. Resa-Infante, P., Jorba, N., Coloma, R. & Ortin, J. The influenza virus RNA synthesis machine: 
advances in its structure and function. RNA biology 8, 207–215 (2011). 
299. Yamanaka, K., Ishihama, A. & Nagata, K. Reconstitution of influenza virus RNA-nucleoprotein 
complexes structurally resembling native viral ribonucleoprotein cores. J. Biol. Chem. 265, 11151–
5 (1990). 
300. Baudin, F., Bach, C., Cusack, S. & Ruigrok, R. W. Structure of influenza virus RNP. I. Influenza 
virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the 
solvent. EMBO J. 13, 3158–65 (1994). 
301. Chan, W.-H. et al. Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals 
amino acids that are crucial for oligomerization and ribonucleoprotein activities. J. Virol. 84, 7337–
45 (2010). 
302. Honda, A., Uéda, K., Nagata, K. & Ishihama, A. RNA polymerase of influenza virus: role of NP 
in RNA chain elongation. J. Biochem. 104, 1021–6 (1988). 
303. Resa-Infante, P., Recuero-Checa, M. A., Zamarreño, N., Llorca, O. & Ortín, J. Structural and 
functional characterization of an influenza virus RNA polymerase-genomic RNA complex. J. Virol. 
84, 10477–87 (2010). 
304. Lee, M. T. M. et al. Definition of the minimal viral components required for the initiation of 
unprimed RNA synthesis by influenza virus RNA polymerase. Nucleic Acids Res. 30, 429–38 (2002). 
305. Newcomb, L. L. et al. Interaction of the Influenza A Virus Nucleocapsid Protein with the Viral 
RNA Polymerase Potentiates Unprimed Viral RNA Replication. J. Virol. 83, 29–36 (2009). 
306. Zhang, S. et al. Biochemical and kinetic analysis of the influenza virus RNA polymerase purified 
from insect cells. Biochem. Biophys. Res. Commun. 391, 570–574 (2010). 
307. Turrell, L., Lyall, J. W., Tiley, L. S., Fodor, E. & Vreede, F. T. The role and assembly mechanism 
of nucleoprotein in influenza A virus ribonucleoprotein complexes. Nat. Commun. 4, (2013). 
308. Kawaguchi, A., Momose, F. & Nagata, K. Replication-coupled and host factor-mediated 
encapsidation of the influenza virus genome by viral nucleoprotein. J. Virol. 85, 6197–204 (2011). 
309. Vreede, F. T., Jung, T. E. & Brownlee, G. G. Model suggesting that replication of influenza virus 
REFERENCES 
 
153 | P a g e  
 
is regulated by stabilization of replicative intermediates. J. Virol. 78, 9568–72 (2004). 
310. Ng, A. K.-L. et al. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA 
binding, oligomerization, and vaccine design. FASEB J. 22, 3638–3647 (2008). 
311. Ye, Q., Krug, R. M. & Tao, Y. J. The mechanism by which influenza A virus nucleoprotein forms 
oligomers and binds RNA. Nature 444, 1078–1082 (2006). 
312. Turrell, L., Hutchinson, E. C., Vreede, F. T. & Fodor, E. Regulation of influenza A virus 
nucleoprotein oligomerization by phosphorylation. J. Virol. 89, 1452–5 (2015). 
313. Mondal, A. et al. Phosphorylation at the Homotypic Interface Regulates Nucleoprotein 
Oligomerization and Assembly of the Influenza Virus Replication Machinery. PLOS Pathog. 11, 
e1004826 (2015). 
314. Boulo, S. et al. Human importin alpha and RNA do not compete for binding to influenza A virus 
nucleoprotein. Virology 409, 84–90 (2011). 
315. Chenavas, S. et al. Monomeric Nucleoprotein of Influenza A Virus. PLoS Pathog. 9, e1003275 
(2013). 
316. Moradpour, D., Penin, F. & Rice, C. M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5, 
453–463 (2007). 
317. Paul, D., Hoppe, S., Saher, G., Krijnse-Locker, J. & Bartenschlager, R. Morphological and 
biochemical characterization of the membranous hepatitis C virus replication compartment. J. 
Virol. 87, 10612–27 (2013). 
318. Romero-Brey, I. et al. Three-Dimensional Architecture and Biogenesis of Membrane Structures 
Associated with Hepatitis C Virus Replication. PLoS Pathog. 8, e1003056 (2012). 
319. Lindenbach, B. D. & Rice, C. M. Unravelling hepatitis C virus replication from genome to 
function. Nat. 2005 4367053 (2005). 
320. Cheng, J. C., Chang, M. F. & Chang, S. C. Specific interaction between the hepatitis C virus 
NS5B RNA polymerase and the 3’ end of the viral RNA. J. Virol. 73, 7044–7049 (1999). 
321. O’Farrell, D., Trowbridge, R., Rowlands, D. & Jäger, J. Substrate complexes of hepatitis C virus 
RNA polymerase (HC-J4): Structural evidence for nucleotide import and De-novo initiation. J. 
Mol. Biol. 326, 1025–1035 (2003). 
322. Huang, Y., Staschke, K., De Francesco, R. & Tan, S.-L. Phosphorylation of hepatitis C virus NS5A 
nonstructural protein: A new paradigm for phosphorylation-dependent viral RNA replication? 
Virology 364, 1–9 (2007). 
323. Hughes, M., Griffin, S. & Harris, M. Domain III of NS5A contributes to both RNA replication 
and assembly of hepatitis C virus particles. J. Gen. Virol. 90, 1329–1334 (2009). 
324. Macdonald, A. & Harris, M. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 
85, 2485–2502 (2004). 
325. Masaki, T. et al. Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is 
Critical for the Production of Infectious Virus Particles. J. Virol. 82, 7964–7976 (2008). 
326. Tellinghuisen, T. L., Foss, K. L. & Treadaway, J. Regulation of hepatitis C virion production via 
phosphorylation of the NS5A protein. PLoS Pathog. 4, e1000032 (2008). 
327. Ascher, D. B. et al. Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for 
RNA. Sci. Rep. 4, (2014). 
328. Lim, P. J. et al. Correlation between NS5A Dimerization and Hepatitis C Virus Replication *. 
REFERENCES 
 
154 | P a g e  
 
(2012). doi:10.1074/jbc.M112.376822 
329. Toshana, ᰔ et al. All Three Domains of the Hepatitis C Virus Nonstructural NS5A Protein 
Contribute to RNA Binding. J. Virol. 84, 9267–9277 (2010). 
330. Huang, L. et al. Hepatitis C Virus Nonstructural Protein 5A (NS5A) Is an RNA-binding Protein 
*. (2005). doi:10.1074/jbc.M508175200 
331. Love, R. A., Brodsky, O., Hickey, M. J., Wells, P. A. & Cronin, C. N. Crystal structure of a 
novel dimeric form of NS5A domain I protein from hepatitis C virus. J. Virol. 83, 4395–403 
(2009). 
332. Tellinghuisen, T. L., Marcotrigiano, J. & Rice, C. M. Structure of the zinc-binding domain of an 
essential component of the hepatitis C virus replicase. doi:10.1038/nature03580 
333. Quinkert, D., Bartenschlager, R. & Lohmann, V. Quantitative analysis of the hepatitis C virus 
replication complex. J. Virol. 79, 13594–605 (2005). 
334. Miyanari, Y. et al. Hepatitis C virus non-structural proteins in the probable membranous 
compartment function in viral genome replication. J. Biol. Chem. 278, 50301–8 (2003). 
335. Neufeldt, C. J. et al. The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear 
Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites. 
PLoS Pathog. 12, (2016). 
336. Appel, N. et al. Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus 
Infectious Particle Assembly. PLoS Pathog. 4, e1000035 (2008). 
337. Kim, Y. K., Kim, C. S., Lee, S. H. & Jang, S. K. Domains I and II in the 5′ Nontranslated Region 
of the HCV Genome Are Required for RNA Replication. Biochem. Biophys. Res. Commun. 290, 105–
112 (2002). 
338. Alaoui-Lsmaili, M. H. et al. The hepatitis C virus NS5B RNA-dependent RNA polymerase activity 
and susceptibility to inhibitors is modulated by metal cations. J. Hum. Virol. 3, 306–16 
339. Quezada, E. M. & Kane, C. M. The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro 
RNA Synthesis in a Template Specific Manner. Open Biochem. J. 3, 39–48 (2009). 
340. Ross-Thriepland, D. & Harris, M. Insights into the complexity and functionality of hepatitis C 
virus NS5A phosphorylation. J. Virol. 88, 1421–32 (2014). 
341. Masaki, T. et al. Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein 
kinase I-α in infectious virus production. J. Virol. 88, 7541–55 (2014). 
342. Lemay, K. L., Treadaway, J., Angulo, I. & Tellinghuisen, T. L. A hepatitis C virus NS5A 
phosphorylation site that regulates RNA replication. J. Virol. 87, 1255–60 (2013). 
343. Ross-Thriepland, D., Mankouri, J. & Harris, M. Serine phosphorylation of the hepatitis C virus 
NS5A protein controls the establishment of replication complexes. J. Virol. 89, 3123–35 (2015). 
344. Ohno, M., Kataoka, N. & Shimura, Y. A nuclear cap binding protein from HeLa cells. Nucleic Acids 
Res. 18, 6989–6995 (1990). 
345. Kittler, R. et al. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat. 
Cell Biol. 9, 1401–12 (2007). 
346. Luo, B. et al. Highly parallel identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. 
U. S. A. 105, 20380–5 (2008). 
347. Cheung, H. W. et al. Systematic investigation of genetic vulnerabilities across cancer cell lines 
reveals lineage-specific dependencies in ovarian cancer. Proc. Natl. Acad. Sci. 108, 12372–12377 
REFERENCES 
 
155 | P a g e  
 
(2011). 
348. Mazza, C., Segref, A., Mattaj, I. W. & Cusack, S. Large-scale induced fit recognition of an 
m(7)GpppG cap analogue by the human nuclear cap-binding complex. EMBO J. 21, 5548–57 
(2002). 
349. Mazza, C., Ohno, M., Segref, A., Mattaj, I. W. & Cusack, S. Crystal Structure of the Human 
Nuclear Cap Binding Complex. Mol. Cell 8, 383–396 (2001). 
350. Monecke, T., Schell, S., Dickmanns, A. & Ficner, R. Crystal structure of the RRM domain of 
poly(A)-specific ribonuclease reveals a novel m(7)G-cap-binding mode. J. Mol. Biol. 382, 827–834 
(2008). 
351. Bian, Y. et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver 
phosphoproteome. J. Proteomics 96, 253–262 (2014). 
352. Rigbolt, K. T. G. et al. System-Wide Temporal Characterization of the Proteome and 
Phosphoproteome of Human Embryonic Stem Cell Differentiation. Sci. Signal. 4, rs3-rs3 (2011). 
353. Olsen, J. V. et al. Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site 
Occupancy During Mitosis. Sci. Signal. 3, ra3-ra3 (2010). 
354. Cantin, G. T. et al. Combining Protein-Based IMAC, Peptide-Based IMAC, and MudPIT for 
Efficient Phosphoproteomic Analysis. J. Proteome Res. 7, 1346–1351 (2008). 
355. Zhou, H. et al. Toward a Comprehensive Characterization of a Human Cancer Cell 
Phosphoproteome. J. Proteome Res. 12, 260–271 (2013). 
356. Mayya, V. et al. Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals 
System-Wide Modulation of Protein-Protein Interactions. Sci. Signal. 2, ra46-ra46 (2009). 
357. Dephoure, N. et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. 105, 
10762–10767 (2008). 
358. Olsen, J. V. et al. Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling 
Networks. Cell 127, 635–648 (2006). 
359. Young-Xu, Y., van Aalst, R., Russo, E., Lee, J. K. H. & Chit, A. The Annual Burden of Seasonal 
Influenza in the US Veterans Affairs Population. PLoS One 12, e0169344 (2017). 
360. Molinari, N.-A. M. et al. The annual impact of seasonal influenza in the US: Measuring disease 
burden and costs. Vaccine 25, 5086–5096 (2007). 
361. Plass, D. et al. Trends in disease burden in Germany: results, implications and limitations of the 
Global Burden of Disease study. Dtsch. Arztebl. Int. 111, 629–38 (2014). 
362. Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 
36–49 (2013). 
363. Quicke, K. M., Diamond, M. S. & Suthar, M. S. Negative regulators of the RIG-I-like receptor 
signaling pathway. Eur. J. Immunol. 47, 615–628 (2017). 
364. Mogensen, T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. 
Clinical Microbiology Reviews 22, 240–273 (2009). 
365. Cao, X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health 
and disease. Nature Reviews Immunology 16, 35–50 (2016). 
366. WHO | World Health Organization. WHO (2018). 
367. Origa, R. et al. Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe 
and effective in patients with hemoglobinopathies. Am. J. Hematol. 92, 1349–1355 (2017). 
REFERENCES 
 
156 | P a g e  
 
368. Choo, Q. L. et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. 
U. S. A. 88, 2451–5 (1991). 
369. Gitto, S., Gamal, N. & Andreone, P. NS5A inhibitors for the treatment of hepatitis C infection. 
J. Viral Hepat. 24, 180–186 (2017). 
ABBRIVATIONS 
 
157 | P a g e  
 
Abbreviations 
Selected protein abbreviations are included in the list. 
 4ESE 4E-sensetive element 
A AAs Amino acids 
 ALREX   Alternative mRNA export  
 ALYREF THO complex subunit 4 
 APA Alternative polyadenylation 
 AREs AU-rich elements 
 ASAP Apoptosis and splicing associated protein complex 
 ATP Adenosine triphosphate 
C CBC Cap-binding complex 
 CE Capping enzyme 
 CPA Cleavage and polyadenylation 
 CPSF Cellular and polyadenylation specific factor 
 CRM1 Chromosome region maintenance 1  
 cRNA complementary RNA 
 CTD C-terminal domain 
 CTE  Constitutive transport element 
D Da Dalton 
 DAA Directly acting antiviral 
 DNA Deoxyribonucleic acid 
 ds Double-stranded 
E eIF Eukaryotic translation initiation factor 
 EJC  Exon junction complex  
 ER Endoplasmic reticulum 
F FG Phenylalanine-glycine 
G GAP  GTPase activating protein 
 GDP  Guanosine diphosphate 
 GEF  Guanine nucleotide exchange factor 
 Gp Guanosine monophosphat 
 GTase RNA guanylyltransferase 
 GTP  Guanosine triphosphate 
H HCV Hepatitis C virus 
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 hnRNP Heterogeneous nuclear ribonucleoprotein particles 
I IAV Influenza A virus 
 IFN Interferon 
 IL6 Interleukin 6 
 IP6 Inositol hexakiphosphate 
 IPMK Inositol polyphosphate multikinase 
 IRES Internal ribosomal entry site 
 ITE Intronless transcript element 
L LCS Low-complexity regions 
 LRR Leucine-rich repeat 
M M Matrix 
 m7G N7-methylguanosine 
 miRNA Micro RNA 
 mRNA Messenger RNA 
 mRNP Messenger ribonucleoprotein particles 
N N7MTase Guanine-N7 methyltransferase 
 NCBP Nuclear cap-binding protein 
 NCR Non-coding region 
 NE  Nuclear envelope 
 NES  Nuclear export signal  
 NLS Nuclear localization signal  
 NMD  Nonsense-mediated decay  
 NP Nucleoprotein 
 NPC Nuclear pore complex  
 NS1 Non-structural protein 1 
 NS5A Non-structural 5A protein 
 nt Nucleotide 
 Nup  Nucleoporins  
 NXF1  Nuclear RNA export factor 1 
 NXT1 NTF2-related export protein 1 
O ORF Open reading frame 
P PABP Poly(A)-binding protein 
 PAMPs Pathogen associated molecular pattern 
 PAP Poly(A) polymerase 
 PARN Poly(A)-specific ribonuclease 
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 PAS Poly(A) signal 
 PHAX Phosphorylated adapter RNA export protein 
 pi Primary 
 Poly(A) Polyadenylated 
 PR8 Mouse adapted laboratory influenza strain A/PuertoRico/8/1934 
 pre Precursor 
 pri Primary 
 PRR Pattern recognition receptor 
R RBD RNA-binding domain 
 RdRp RNA-dependent RNA polymerase 
 RISC RNA-induced silencing 
 RNA Ribonucleic acid 
 RNGTT RNA guanylyltransferase and 5´triphosphatase 
 RNP Ribonucleoprotein particle 
 RRM  RNA recognition motif  
 rRNA  Ribosomal RNA 
 rRNP Ribosomal ribonucleoprotein particles 
 RTE RNA transport element 
 RTPase RNA triphosphatase 
S S  Svedberg unit 
 shRNA short hairpinRNA 
 siRNA  Small interfering RNA 
 Sm Sphingomyelin 
 SMN Survival of motor neuron  
 snoRNA Small nucleolar RNA 
 snRNA Small nuclear RNA 
 snRNP Small nuclear ribonucleoprotein particles 
 SR  Serine-arginine 
 ss Single-stranded 
 SSCR  Signal sequence-coding region  
T TGS1 Trimethylguanosine synthase 
 TMG Trimethylguanosine 
 TREX  Transcription export  
 tRNA Transfer RNA 
 TUTase Terminal uridylyl transferase 
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U U/G Uridylate- and guanylate-rich 
 UBA Ubiquitin-associated 
 UTR  Untranslated region  
V vRNA Viral RNA 
 vRNP Viral ribonucleoprotein particles 
 VSV Vesicular stomatitis virus  
X XPO Exportin 
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